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ABSTRACT
A new microdialysis sampling method and microfluidic device were developed in vitro. The method
consisted of using up to four microdialysis sampling probes connected in series to evaluate the relative
recovery (RR) of different model solutes methyl orange, fluorescein isothiocyanate (FITC)-dextran average
mol. wt. 4,000 (FITC-4), FITC-10, FITC-20, and FITC-40. Different flow rates (0.8, 1.0, and 1.5 µL/min)
were used to compare experimentally observed relative recoveries with theoretical estimations. With
increasing the number of probes in series, the relative recovery increases and ~100% (99.7% ± 0.9%)
relative recovery for methyl orange was obtained. For larger molecules such as fluorescein isothiocyanate
(FITC)-dextran average mol. wt. 4,000 (FITC-4), FITC-10, FITC-20, and FITC-40, RR of 66.3% ± 0.0%,
39.4% ± 0.6%, 18.7% ± 0.1%, and 7.7% ± 0.1%, respectively, were obtained using four microdialysis
sampling probes in series at 0.8 µL/min. Using theoretical estimations, the number of microdialysis probes
in series needed to achieve 99% RR was determined for each solute. The theoretical estimations started
deviating from experiments at mol. wt. 10,000 (FITC-10). For example, the deviations from experiments for
FITC-10, FITC-20, and FITC-40 were +52%, +149%, and +179% respectively. On the other hand, methyl
orange and FITC-4 theoretical estimations were closer to the experiments (-1%, underestimation, and
+15%, overestimation).

The method developed for this dissertation was miniaturized in a

polydimethylsiloxane (PDMS) microfluidic device having a flat polyethersulfone membrane and seven
micro-channels connected in series. Push-pull experiments determined that the optimal setting for this
microfluidic device prototype during the collection of methyl orange was 0.2 µL/min-1.0 µL/min. The relative
recovery of methyl orange using this setting was 78.8% ± 2.5%. This result indicated that a working
microfluidic device prototype was developed. Further optimizations need to be performed to reach the same
level as the microdialysis probes in series method. All the work conducted to achieve the development and
miniaturization of the microdialysis probes in series approach is presented in this dissertation.

© 2018 by Randy Francisco Espinal Cabrera
All Rights Reserved
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GLOSSARY
Abbreviations:
ANOVA

Analysis of variance

ELISA

Enzyme-linked immunosorbent assay

EE
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Chapter 1. Introduction to microdialysis sampling and microfluidic devices
Microdialysis sampling

1.1.1

History
Microdialysis sampling is a diffusion-based separation technique commonly used to sample

biomolecules from fluid compartments (Figure 1.1) in mammals such as humans,1, 2 monkeys,3, 4 rodents,5
and pigs.6, 7 Microdialysis probes are composed of a concentric semi-permeable membrane, outer support
membrane layer, inner cannula, and inlet and outlet tubing, see Figure 1.2. Microdialysis samples the
extracellular fluid (ECF) or the fluid between the cells, because this is where chemical transport and
chemical communication occurs. Proteins, electrolytes, and other chemicals travel in this region and are
able to be collected during microdialysis sampling experiments.8 The intracellular fluid (ICF), on the other
hand, is the fluid inside the cell enclosed by plasma membranes. This region is closely regulated by the
body and makes up ~60% of the total water in the human body.8 The amount of water present in the human
body varies depending on the type tissue from 8% in the teeth to 80-85% in the brain.8 Microdialysis
sampling has been widely used to collect many different classes of molecules from extracellular fluid (ECF)
space with more than 15,000 publications documenting the collection of various solutes of biomedical
interest.9,

10

Like many separation techniques microdialysis sampling went through an evolutionary usage

and development process.

Figure 1.1. Schematic representation of fluid compartments in the human body (Redrawn from reference
11).

1

Figure 1.2. Schematic representation of traditional microdialysis sampling experiment setup.

Prior to microdialysis sampling, push-pull technique and dialysis bags were the preferred methods
to collect biomolecules from living systems. Briefly, push-pull technique consists of pushing a solution
through a cannula into a sampling site and pulling the solution by an adjacent cannula. 12 Push-pull
technique fell out favor due to the fact that it was difficult to operate and caused a significant amount of
tissue damage.12 In 1966 Bito et al. were the first to propose the use of dialysis bags, sometimes called
sacs for the collection of biomolecules from the brain of dogs.9, 12, 13 One of the problems with this approach
was that you could only take one sample per dialysis bag implanted.13 Moreover, these dialysis bags were
implanted for more than two months in order to study concentration changes of the biomolecules of
interest.12 As it is well-known, longer implantation periods lead to encapsulation of any implanted device by
living systems foreign body response, when the immune system is unable to destroy it and try to isolate
it.14, 15 Foreign body response is outside of the scope of this dissertation and it is not going to be addressed
in detail here.
Another improvement towards to what we nowadays called microdialysis sampling was
demonstrated by Delgado et al. six years later (1972). Delgado and colleagues further developed the
dialysis bag technique and called it dialytrode.9, 13,
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The dialytrode worked by perfusing a solution into a

dialysis bag and moving it to an area where it could be collected and analyzed. 9 This process mirrored
today’s microdialysis sampling in which a solution is infused into a microdialysis probe and then collected
from an outlet tubing.13
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Finally, Ungerstedt et al. replaced the dialysis bags with hollow fibers and successfully measured
neurochemicals in the brain of rats.9, 12 Since then, microdialysis sampling became the preferred sampling
technique to study biomolecules in living systems.
Commercially available microdialysis probes, as shown on Figure 1.3, consist of two fluorinated
ethylene propylene (FEP) pieces of tubing (inlet and outlet) and a cylindrical hollow fiber semipermeable
membrane of 0.5 mm in diameter. Semipermeable membranes are typically made of either
polyarylethersulfone (PAES) or polyethersulfone (PES). Other materials such as polycarbonate/polyether
(PC), polyamide17 and cellulose acetate are used as microdialysis probe membranes as well. Microdialysis
probes of different membrane lengths to sample from subcutaneous (10 mm) and brain (4 mm) spaces can
be purchased from different vendors.18 Also, microdialysis probes having membranes of different molecular
weight cutoffs (e.g. 100 kDa and 1000 kDa) are commercially available.

Figure 1.3. Picture of a commercially available CMA 20 microdialysis probe from Harvard Apparatus.
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1.1.2

Mechanism
As previously mentioned, microdialysis sampling is a diffusion-based separation technique.

Traditionally, microdialysis experiments require a microdialysis probe, gas-tight syringe, syringe pump, and
perfusion fluid (Figure 1.2). During microdialysis sampling the perfusion fluid or perfusate is selected so
that its chemical composition matches the chemical properties of their milieu (ECF) such as a pH and ionic
strength.19 Matching the chemical properties of the perfusion fluid to the environment in which it is perfused
in is important to avoid disrupting the biology of the collection site or tissue.
Microdialysis sampling experiments can be conducted either in vivo or in vitro. In vitro microdialysis
sampling experiments are conducted to gain information about the efficiency of the microdialysis probes
and transport behavior of biomolecules. For example, microdialysis sampling has been used in vitro to
sample peptides and proteins in highly complex bioprocesses.20 However, most application are conducted
in vivo. During in vivo microdialysis the sampling site is a living system’s fluid compartment (e.g. ECF). On
the other hand, the sampling site during in vitro microdialysis sampling experiments is a synthetic reservoir
aimed to mimic the physicochemical conditions of living system’s fluid compartments. In some cases, a
small plastic vial or any other reservoir is used as sampling site. This causes several issues when
correlating in vitro experiments to in vivo since the concentration of analyte in fluid compartments is never
precisely known and can change rapidly overtime. Moreover, the tortuous path that biomolecules diffuse
through during in vivo collections is significantly larger than in vitro collections, see Figure 1.4.21 A new
approach in which several or four microdialysis sampling probes are connected in series was developed
for this dissertation. This microdialysis in series approach seeks to address the problem of never knowing
the concentration of analyte in fluid compartments by getting to an equilibrium concentration as the surface
area of the microdialysis probe increases as well as the residence time. This issue will be addressed in
more detail later in the chapter.
The main driving forces acting on microdialysis sampling technique are hydraulic and concentration
gradient. In order to create a hydraulic force during microdialysis sampling, a positive pressure (flow rate)
is generated by a pump, typically a syringe pump. The flow rate generated by the syringe pump must be
high enough to overcome the pressure at the outlet tubing and push the perfusion fluid.
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Figure 1.4. Comparison of in vivo and in vitro diffusion pathways during microdialysis sampling.21 Adapted
from reference 21, Copyright 2017, with permission from Elsevier.

The pressure at the outlet tubing is atmospheric (1 atm), since the outlet is open to the room where
experiments are conducted. The resultant of pressure difference (ΔP) generated during microdialysis
sampling experiments is called flow rate (Q). Flow rate represents the amount of volume that travels in the
tubing as a function of time and its units are volume/time (µL/min). This is much like electric current which
represents the amount of electric charge flowing in an electric circuit when a voltage difference in generated.
Engineers take advantage of the latter to study flow behavior using electric circuits. This is very useful for
prototyping. The mathematical approach used to accomplish this is called equivalent circuit theory. 22
The pressure difference is typically positive (+ΔP) in traditional microdialysis, or negative (-ΔP),
push-pull and vacuum ultrafiltration. It is good to point out that a +ΔP can be generated during push-pull
microdialysis, but not during vacuum ultrafiltration, see Figure 1.5. As stated on section 1.1.1, the push-pull
perfusion technique was one of the first microdialysis sampling techniques developed. The technique
consists of pushing a solution through a cannula into a sampling site and pulling the solution by an adjacent
cannula.12 One of the problems with this technique was that it causes a significant amount of tissue damage
and fluid loss.12
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Figure 1.5. Schematic representation of pressure profile along microdialysis probe.23 (a) push; (b) pull; (c)
push and pull. Adapted from reference 23, Copyright 2017, with permission from Elsevier.

In contrast, push-pull microdialysis was developed to eliminate fluid loss. In push-pull microdialysis
technique the perfusion fluid is normally pushed at a lower pressure into the inlet of the microdialysis probe
and pulled at a higher pressure from the outlet (dialysate). The negative pressure difference ensures that
the perfusion fluid is not loss across the microdialysis probe membrane. According to Polak, “push-pull was
the most effective method for the elimination of fluid loss or gain during the sampling by probes of high
MWCO [e.g. 100 kDa].”24 On other hand, microdialysis sampling probes of 15 kDa MWCO or smaller were
not influenced by pumping methods.24 This could be due to the fact that membranes of smaller pore size
are least susceptible to imbalance between the hydrostatic and osmotic pressure or fluid loss due to osmotic
flux.25
Normally, during a microdialysis sampling experiment the perfusion fluid lacks the analyte of
interests. This type of experiment is called relative recovery experiment. A concentration gradient is
generated across the microdialysis probe membrane, during this experiment, and analytes diffuse from
outside the membrane to the inner part of it, see Figure 1.6.
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To explain, the solution located outside the microdialysis probe membrane must have a higher
concentration than the perfusion fluid located inside the microdialysis probe membrane. This allows the
target biomolecules to diffuse from outside of the membrane to the inside and be carried by the perfusate
to the microdialysis sampling probe outlet. The solution composed of perfusate and analyte is called
dialysate. The dialysate is the solution that is collected and analyzed during microdialysis sampling
experiments, see Figure 1.6. Unlike the perfusion fluid, the dialysate contains the analyte of interest during
microdialysis sampling collections. On the other hand, during pharmacokinetic studies, for example, in
which drugs need to be delivered in situ to study their interactions with their milieu, the perfusate
concentration is not zero. This microdialysis sampling mode is called delivery. Delivery is essentially the
reverse process of collection mode.
The efficiency of microdialysis sampling is represented as either relative recovery (RR) or extraction
efficiency (EE).26,

27

Relative recovery is defined as the ratio of dialysate concentration or outlet

concentration (Coutlet) and the concentration of the analyte far away from the collection point (C sample,∞).27
This ratio, relative recovery, for an in vitro system is defined as: 28

RR =

Coutlet
Csample,∞

Equation 1.1

Figure 1.6. Schematic representation of the diffusion-based microdialysis process.
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Relative recovery can also be expressed as: 28
RR = 1 − exp {

−1

}

Qd (Rd +Rm +Rq )

Equation 1.2

The terms of equation 1.2 have been defined in detail by Bungay et al. as shown in Figure 1.7. 29 In Equation
1.2, Q d represents flow rate, R q mass transport resistance of the quiescent medium external to the
microdialysis probe, R d mass transport resistance of the dialysate, and R m mass transport resistance of the
microdialysis probe membrane. The difference between Equation 1.1 and Equation 1.2 is that Equation 2
includes the resistances involve in the microdialysis sampling process and its flow rate. These resistances
in term include all the different diffusivity and kinetic processes involved in overall mass transport. 22

Figure 1.7. Bungay microdialysis sampling mass transport model and strategies to minimize the influence
of mass transport resistances on the relative recovery (RR).26, 29

Equation 1.1 is more commonly used during microdialysis sampling experiments. For experiments in which
a deeper understanding of the sampling site is needed, Equation 1.2 is used. However, the resistance
values are often hard to get. Equation 1.2 is mostly used for microdialysis sampling modeling and theoretical
work. Relative recovery differs from absolute recovery or recovery, a term commonly used in analytical
chemistry separation processes, in that the relative recovery is concentration based and absolute recovery
is mass based, see Figure 1.8.12, 21
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Figure 1.8. Relationship between relative recovery, absolute recovery, and flow rate. 12 (Redrawn from
reference 12)

As the flow rate increases more mass overall is collected, absolute recovery, but a larger volume and
smaller mass of analyte or lower concentration relative to the concentration outside the membrane is
collected (relative recovery). Relative recovery is commonly used during microdialysis experiments,
because the concentration of analyte outside the membrane is unknown during in vivo experiments.
Sometimes this causes confusion among researchers that are not familiar with microdialysis sampling
relative recovery. Figure 1.7 illustrates that the resistances denoted in this equation depend on the effective
membrane length (L), which in terms is directly related to relative recovery. This means that a microdialysis
probe with a membrane of large surface area will have a higher relative recovery than a probe with a
membrane of small surface area (all other parameters being equal). The membrane length is a key feature
useful to reduce the influence of resistances on relative recovery. Microdialysis sampling technique has
several advantages and drawbacks as shown in Table 1.1, modified from the Kloft and Plock’s review about
microdialysis implementation in applied life-science.30
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Table 1.1. Advantages and drawbacks of microdialysis sampling.30
Advantages

Drawbacks

Collection of biomolecules at site of action

Size limitation for molecules of interest

Direct delivery to target tissue

Determination of mean concentrations overtime interval

On-line measurements

Calibration necessary as recovery does not reach 100%
Requires an analytical method with a low limit of

“Analytically clean” samples
quantitation capable of dealing with small volumes
Simultaneous sampling at multiple sites

Risk of tissue trauma 9

Applicability to almost every organ

Limited time resolution ≥1 min; typically 10 min 9

Applicability in conscious animals

1.1.3

Limitations
Calibration methods
A common issue that continues to frustrate many microdialysis sampling users is that of in vivo

calibration. There are numerous reasons why calibration of implanted microdialysis probes in vivo is
extremely challenging. The primary reason for this has been recognized for decades is that tissues are not
homogeneous structures and there are typically numerous inputs and outputs that can be difficult to model
in vitro.31, 32 In vivo microdialysis calibration methods have different problems associated with their use and
in many cases can be quite cumbersome from an experimental perspective. It is good to point out that the
term calibration in this context means to determine the concentration of the target analyte outside the probe
or from the sampling site. This cannot be confused with the more commonly used definition of calibration,
in which instruments must go through during experiments. These calibration methods used for in vivo
calibration require steady-state concentrations for measurements.33
1.2.1

In vitro
The first calibration method used to correlate Coutlet to Csample,∞ was the in vitro calibration method.34

The way how in vitro calibration method works is by determining the concentration (relative recovery) of a
standard solution of the biomolecule of interest in vitro and relating it to the in vivo relative recovery.12
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This method assumes that the mass transport resistance of the membrane is greatest through the
membrane and not the tissue.34 The problem with this assumption is that, as stated before, the tortuosity
of in vitro experiments is almost non-existence compared to in vivo experiments. Nevertheless, the kinetic
processes that drive the differences between in vivo and in vitro calibration are similar.
Another problem with this method and that few researchers have addressed, is that the pressure
inside sampling sites (in vivo) is not constant, see Figure 1.9. Every time a microdialysis probe is implanted
in any tissue the transmembrane pressure of the semipermeable membrane will increase. For example,
the pressure in the cranium of humans or intracranial pressure can vary from 2 to 7 mmHg in healthy
patients. The intracranial pressure of injured patients can be more than 50 mmHg. 35 Still several factors
such as age, body posture, and clinical conditions can affect intracranial pressure.36, 37
This is far different than collections conducted in vitro in which only atmospheric pressure is present outside
the microdialysis probe membrane. When the in vitro calibration method is used the relative recovery of the
analyte of interest is off by a factor of two or three compared to the true concentration of the analyte in the
sampling site.34

Figure 1.9.Variation of pressures within the human body. 37 (From reference 37 with permission from the
Creative Commons Attribution License, open access, see appendices)

1.2.2

No-net flux or zero-net-flux
The method of zero-net-flux method requires steady-state concentrations and if they are present

in the tissue flow rates can be sequentially changed.12, 38
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This method requires a significant amount of experimental time to cycle through the concentrations
necessary to straddle the suspected in vivo concentration. According to Hershey and Kennedy, no-net-flux
is the most popular calibration method for in vivo microdialysis sampling experiments.39 However, this
method requires steady-state conditions and not all analytes are at steady-state during experiments.
1.2.3

Internal standards
The internal standards calibration method requires steady-state conditions as the no-net-flux

method.34 Stable-isotope labels or other suitable analogs for small molecules are used for this method, but
can be problematic or prohibitively expensive for different solutes including drugs, peptides and proteins.
1.2.4

Slow perfusion
Like its name implies, the slow perfusion microdialysis sampling calibration method consists of the

slow perfusion of a perfusion fluid into a microdialysis probe. This method takes advantage of the fact that,
RR ∝

1
Qd

. The slower the flow rate used, the higher the residence time of the perfusate. Higher residence

times allow the perfusion fluid more time to interact with the fluid surrounding the microdialysis probe
membrane. Hence, more time for the analyte to travel from outside the membrane into the perfusion fluid
(inside the membrane). The aim of this method is to allow enough time for equilibrium to occur between the
perfusion fluid and the fluid surrounding the microdialysis probe membrane. One of the problems with the
slow perfusion method is that it requires very long collection times in order collect enough sample (e.g. 50
µL for some ELISA kits) to analyze it. Long collection times lead to sample evaporation .
Membranes
Another limitation of microdialysis sampling is that the relative size of semipermeable membrane
pores is expressed as molecular weight cutoff (MWCO). Molecular weight cutoff is one of the factors that
influence the relative recovery of biomolecules, according to Chaurasia (Table 1.2). 38 Snyder et al. stated
that as the size of the analyte approaches to the size of the microdialysis probe pore size a reduction in the
relative recovery of the analyte is observed due to an increase in the microdialysis membrane resistance. 40
The latter as compared with smaller analytes.40 MWCO allows researchers to choose microdialysis probes
based on the molecular weight of biomolecules.
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However, there are several issues with using MWCO as an indication of the pore size of microdialysis probe
membranes. First of all, there is not a standardized method to determine MWCO of semipermeable
microdialysis probe membranes. Some companies do not disclose which method they use, and methods
can vary from company to company.41, 42, 43, 44 One method used to determine MWCO of microdialysis probe
membranes is equilibrium dialysis, in which a semipermeable membrane is placed in between two enclosed
chambers.22 The membrane serves as a barrier to separate both chambers. Several chemical compounds
of different molecular weights are placed in one chamber and the other chamber is filled with a buffer
solution. This is done to generate a concentration gradient across the membrane “similar” to the
microdialysis collection mode previously mentioned. Next, the enclosed chambers are incubated until
equilibrium is reached.42 The problem with using this method to determine MWCO of microdialysis probe
membranes is that microdialysis sampling works differently than equilibrium dialysis.

Table 1.2. Chaurasia’s list of factors influencing microdialysis sampling recovery. 38
1)

Perfusion flow rate

2)

Sample flow rate

3)

Temperature of the tissue or dialysis target

4)

Diffusion of the substance within the sample medium

5)

Diffusion rate in dialysis membrane

6)

Molecular weight cutoff of the dialysis

7)

Chemical interaction between the analyte and the membrane

8)

Surface area of the dialysis membrane (length and diameter of the probe)

9)

Blood flow rate

10) Metabolism rate
11) Uptake into cells
12) Extent of tissue vascularization
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Microdialysis sampling is a dynamic process driven mainly by pressure differences or flow rates in
which a perfusion fluid is continually being perfused, so equilibrium is never reached between inner and
outer compartments of microdialysis probe membranes. 42,

45

Some companies define MWCO as the

molecular weight of a molecule that is 90% retained by the membrane or 90% of the total molecules that
diffuses across the membrane.41, 43, 44 Depending on the company the percentage of retention can oscillate
from 60 to 90%.41, 44 Several approaches are used by researchers and companies to minimize this problem.
For example, Li and Cui stated that, “Theoretically, the MWCO of microdialysis membrane three times
greater than the molecular weight of the target molecule is sufficient to permit diffusion across the dialysis
membrane.”46 This approach ensures that, on average, membrane pores are larger than target molecules.
In contrast, CMA Microdialysis A Harvard Apparatus Company advises to choose a microdialysis probe
membrane four times greater than the molecule of interest.47 Another example, Bioanalytical Systems, Inc
(BASi) claims on their tech note 1013 that their microdialysis probes have a molecular weight cutoff range
of 30 to 38 kDa (kilodaltons), but during microdialysis experiments they would not expect to collect any
chemical compounds higher than 6 to 7 kDa.42 Compared to the other two examples, BASi would
recommend to choose microdialysis probes five times greater than the analyte to be sampled. As can be
seen there is not a consensus on what molecular weight cutoff really means adding more complexity to
microdialysis sampling experiments. The ultimate goal would be to have a more robust microdialysis
sampling probe with a minimal membrane transport resistance for analytes of different molecular weights.
Mathematical models
Many biomolecules have their concentrations changed during disease states. Microdialysis
sampling technique allows researchers to monitor those changes in real-time. However, as mentioned
before, microdialysis calibration methods can only give an approximate value of the concentration. For
example, knowing the concentration of glucose is vitally important for people suffering from diabetes. This
information facilities physicians regulate their glucose levels.
Several attempts to solve this problem have been made utilizing different strategies, see Table 1.3. 9, 21
According to Kehr, the first researchers to identify and try to quantify relative recovery during microdialysis
sampling in vivo experiments were Ungerstedt and Zetterstrom.21
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Their method assumes that microdialysis sampling in vitro recoveries, under quiescent conditions, were the
same as in vivo recoveries.21 This would allow them to determine the relative recovery of different
biomolecules present in different tissue spaces. Their idea was that, if you used the same conditions
(microdialysis sampling probe and flow rate) used to determine recoveries in vitro, when used in vivo they
must be equivalent. However, there are a lot of problems with their assumption.9 Some these problems
were previously addressed in this chapter.
Firstly, the concentration of biomolecules is generally not static in living systems, they change
rapidly which is not the case for in vitro microdialysis experiments. However, some studies have found that
for some concentrations those changes are generally static and stable for long periods of time. Another
problem, as stated before, is that the tortuosity for in vivo microdialysis is significantly different than in vitro,
see Figure 1.4.

Table 1.3. Kehr’s classification of microdialysis sampling mathematical and empirical models. 21
Type of model

Author (s)

Year (s)

Ungerstedt and Zetterstrom

1982

Jacobson

1985

Lerma

1986

Lönnroth

1987

Ekblom

1992

Merlo Pich

1993

Lindefors and Amberg

1989

Benveniste et al.

1989, 1990

Bungay et al.

1990

Morrison

1991

Empirical

Mathematical

Benveniste et al. determined that microdialysis sampling recoveries of potassium (K +) and calcium
(Ca2+) ions in vitro were higher than those measured in vivo.31 They used ion-selective microelectrodes in
order to measure the ions concentration in the dialysate.
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Due to this observation a tortuosity factor, λ, was introduced to correct for the difference in tortuosity for in
vivo and in vitro microdialysis experiments.31 This factor was defined by Nicholson and Philips in 1981 and
states that: 31, 48, 49
𝐷

λ2 = 𝐷𝑞

Equation 1.3

𝑒

Where λ represents the tortuosity factor, Dq is the diffusion coefficient in the quiescent medium, and De the
diffusion coefficient in the extracellular space. Benveniste and colleagues strategy worked well for
microdialysis sampling collections of Ca2+, but not so well for neurotransmitters such as glutamate and
dopamine.31
An empirical method called flow rate method was developed by Jacobson et al. in 1985, see Figure
1.10.9, 50, 51 According to Chefer et al.,“The flow rate method was one of the first empirical methods designed
to determine extracellular concentration by determining the relationship between perfusate flow rate, the
active area of the membrane, and the mass transfer coefficient and then extrapolating to the case of zero
flow rate.”9 Jacobson et al. pointed out that the mass transfer coefficient (k) of any molecule can be
determined experimentally during microdialysis sampling by measuring its relative recovery at different flow
rates and plotting the results to find the slope or k, see Figure 1.10.50, 51 Bungay et al., stated that the overall
probe-external medium permeability, P, is equivalent to the mass transfer coefficient of Jacobson et al., k.29
Thus:

PS =

1

Equation 1.4

Rd + Rm + Rq

In Equation 1.4, S or A is surface area of the microdialysis probe membrane, R q mass transport
resistance of the quiescent medium external to the microdialysis probe, R d mass transport resistance of
the dialysate, and R m mass transport resistance of the membrane, see Figure 1.7. To determine the mass
transfer coefficient, k, of any biomolecule using microdialysis sampling technique, Equation 1.2 and 1.4 are
combined:

RR = 1 − exp {

−1

}

Qd (Rd +Rm +Rq )

Equation 1.2
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𝑘A = (

1
Rd + Rm +Rq

)

Equation 1.4

Note that in Equation 1.4 P and S were replaced by k and A.
Thus:

RR = 1 − exp (

−𝑘A
Qd

)

Equation 1.5

Rearranging Equation 1.5:
𝑘𝐴 = [−ln(1 − RR)]Q d

Equation 1.6

Equation 1.6 can be used only if (1 − RR) ≠ 0.

Figure 1.10. Jacobson et al. microdialysis sampling method. 50, 51 Reprinted from reference 51, Copyright
2017, with permission from Elsevier. Original figure reference 50, Copyright 2017, with permission from
Elsevier.

By plotting –ln (1 − RR) as a function of Q d-1, the product kA can be obtained from the slope, see
Figure 1.10. This is a very useful tool developed by Jacobson et al., but it assumes steady-state conditions.
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Most microdialysis sampling mathematical methods make this assumption. This method was used to
estimate the relative recovery of methyl orange and fluorescein isothiocyanate-dextrans (FITCs) during
microdialysis probes in series approach as denoted in chapter 4.
Approaches to improve relative recovery
Microdialysis sampling relative recovery is a multifactorial problem which makes it a challenging
problem. Chaurasia listed a number of factors such as flow rate, temperature, diffusion properties,
molecular weight cutoff, and so on that influence the relative recovery of biomolecules during microdialysis
sampling, see Table 1.3.38 Researchers have developed several strategies to improve the collection of
biomolecules such as cytokines using microdialysis sampling.27, 52, 53
1.5.1

Affinity agents

Duo et al. developed a method to improve cytokine relative recovery using affinity agents such as
antibodies and heparin attached to polystyrene microspheres, see Figure 1.11. 53 Their method consists in
perfusing polystyrene microspheres with affinity agents chemically attached to their surface. For example,
they chemically attached antibodies to the surface of the microspheres and perfused them through the
microdialysis probe during cytokines collection to increase cytokines diffusion across the membrane
pores.53,

54

Finally, cyclic oligosaccharides called cyclodextrins have also been used as affinity agents to

improve microdialysis relative recovery of molecules.55
1.5.2

Mechanical approaches
Recycling or recirculation
Another way to improve the relative recovery of biomolecules during microdialysis sampling

experiments is by increasing the residence time of the perfusion fluid at the microdialysis probe
semipermeable membrane (inner site). As mentioned before this can be achieved by using slow flow rates;
however, several issues arise when slow flow rates (< 0.5 µL/min) 56, 57 alone are used. Some of these
issues are sample evaporation and longer collection time.
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Figure 1.11. Microdialysis sampling using affinity agents approach.53 Reprinted from reference 53,
Copyright 2017, with permission from Elsevier.

Figure 1.7 shows that from a theoretical stand point increasing the surface area and length of the
microdialysis sampling membrane will improve relative recovery. The problem with increasing the length of
microdialysis probe membranes is that you are limited by the size of the sampling site. In other words,
extracellular fluid compartments in living systems are very small relative to the current microdialysis
sampling probes. Microdialysis sampling probe membranes of 4 or 10 mm in length are commonly used.
However, depending on the need smaller membranes (1 mm) can be used. In general, the size of the
sampling site dictates the length of the microdialysis probe membrane.
In 1986 Lerma et al. were the first to design a microdialysis sampling probe having a closed loop
to recirculate perfusate (Figure 1.12) for in vivo measurements of amino acids in rat hippocampus. 58 They
used this method to increase the residence time of the perfusate and predict the concentration of amino
acids in the extracellular fluid space. Lerma and colleagues made a diffusion mathematical model for this
system. The assumptions of their model were that simple diffusion guided biomolecules across the
membrane, concentration was constant around the probe, and steady-state conditions.58 Equation 1.7
summarizes their method. The concentration of perfusate is represented by c, A represents extracellular
fluid concentration of biomolecules, K is apparent diffusion constant across the membrane, and t residence
time.58
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At t = 0 or beginning of perfusion, the concentration of the perfusate (c) is zero, but after sufficiently long
times (t → ∞) the concentration of the perfusate will be equal to the concentration of biomolecules in the
extracellular fluid. In other words, the perfusate and extracellular fluid will be at equilibrium allowing to
determine the concentration of the extracellular fluid for any biomolecule.
c = A (1 – e-Kt)

Equation 1.7

Figure 1.12. Lerma et al.’s microdialysis sampling circulation experimental set up. 58 Reprinted from
reference 58, Copyright 2017, with permission from Elsevier.

Sternberg et al. eight years later, in 1994, developed a calibration method for glucose sensors
using a microdialysis sampling recirculation device to determine subcutaneous concentrations of glucose
in humans.59
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Their method consisted on recirculating a perfusion fluid (phosphate saline), using a peristaltic pump, inside
a microdialysis probe until a concentration equilibrium was reached between the glucose concentration
outside the microdialysis probe membrane and the inside. Similar to Lerma et al.’s work, they increased
the residence time of the perfusion fluid. This in terms helped them determine the glucose concentration
present in the tissue. Sternberg et al. listed five reasons why their recirculation method was very effective,
see Table 1.4.59 One of the reasons was that a small amount of liquid is continuously in contact with the
extracellular fluid preventing any adverse responses from the sampling site. 59
Table 1.4. Sternberg et al. reasons why their calibration method is effective. 59
a) Microdialysis probe implantation does not interfere with results within 30 minutes
after implantation
b)

Only a small amount of volume is in contact with the extracellular fluid continuously
minimizing any adverse reaction

c)

The dialysate is constantly stirred

d)

Surface area and residence time allow for a total equilibrium to occur

e)

Blood contamination is avoided by using a semipermeable membrane

In 1995, Sternberg at al. published the same paper or similar than their 1994 recirculation paper,
but this time they called their method “the recirculator”.60 In this work they estimated subcutaneous glucose
concentration in humans and continuously monitored the concentration changes using a recycling system. 60
They found that fifteen cycles were needed to achieve equilibrium between recirculated phosphate buffer
saline inside microdialysis probe and plasma glucose or standard solution of glucose outside of it.
One interesting observation about Lerma et al. work and Sternberg et al’s is that as far as this
author knows since 1995 no other work further investigating or improving this method have been published.
Their recirculation method seems to be a very effective way to eliminate microdialysis sampling calibration
methods. The preliminary work for this dissertation consisted of a similar method of recirculation or recycling
microdialysis sampling to improve relative recovery and eliminate microdialysis sampling calibration
methods, see Figure 1.13. This will be covered in chapter 2 in more detail.
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Transmembrane pressure
Microdialysis sampling is not only driven by diffusion, but also by hydraulic pressure. According to
Bungay et al.,”It is customarily assumed that no significant amount of the perfusate fluid is loss across the
probe membrane and that solute exchange across the membrane occurs by diffusion.” 61 This assumption
causes errors during the interpretation of experiments conducted using microdialysis sampling probes of
high molecular weight cutoff (e.g., 100 kDa) membranes. However, understanding how pressure influences
the relative recovery of biomolecules during microdialysis sampling experiments can be very useful.
Bungay et al. demonstrated how relative recovery of biomolecules can be improved by changing
the transmembrane pressure of microdialysis sampling probes, see Figure 1.14.

Their experiment

consisted on changing the height of the collection vial or the outlet tubing of a microdialysis sampling probe
to change the transmembrane pressure. To explain, when the vial is elevated an increase in backpressure
or hydraulic resistance is generated inside the microdialysis probe. This causes an increase in fluid loss
across the membrane. On the other hand, when the vial is lowered a positive pressure is generated inside
the microdialysis probe drawing liquid from outside the probe to inside. A fluid gain is observed.

Figure 1.13. Diagram of setup used for microdialysis sampling recycling flow method experiments.
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This gain or loss was defined by Bungay and colleagues as an ultrafiltration factor, see Equation 8. In this
equation, Qin and Qout represent the flow rate of the perfusion fluid and the dialysate respectively. For fluid
loss Qout<Qin and for fluid gain Qout>Qin.61

𝑓𝑄 ≡

𝑄𝑖𝑛 − 𝑄𝑜𝑢𝑡
𝑄𝑖𝑛

Equation 1.8

Recently, Chu et al. found a direct relationship between fluid recovery (FR), and static pressure. 62,
63

They studied the importance of transmembrane pressure in fluid recovery by using a pressured chamber

that they designed, see Figure 1.15.64 Their work consisted on changing the pressure outside and inside
the microdialysis probes systematically. They used four CMA 71 microdialysis sampling probes for their
experiments having membranes of 100 kDa MWCO and 10 mm in length. These probes were placed inside
a chamber and each probes were connected to syringe pumps. 62 It is good to point out that these probes
were not connected in series. The chamber allowed them to control the pressure outside the microdialysis
probes. It is a common practice to add osmotic agents during microdialysis sampling experiments that use
microdialysis probes having membranes of 100 kDa or larger MWCO. These agents such as dextrans
counterbalance the pressure inside the probe. This approach helps reduce fluid loss during microdialysis
sampling experiments and improve relative recovery of biomolecules.

Figure 1.14. Transmembrane pressure experimental set up to improve microdialysis sampling recovery. 61
Reprinted from reference 61, Copyright 2017, with permission from Elsevier.
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Figure 1.15. Pressure chamber engineered to study transmembrane pressure influence on recovery. 63, 64
(From reference 64, open access article, with permission to reuse under the terms of the Creative Commons
License, see appendices for details)

The experiments described by Chu et al. were the first to study the influence of osmotic,
transmembrane, hydraulic, and outside probe or sampling site pressure on fluid recovery during
microdialysis.62 Their work could lead to an automated microdialysis sampling system in which pressure
sensors control the pressure in the system. For example, during in vivo experiments the pressure outside
microdialysis probes changes depending on the sampling site internal pressure. This impacts the
transmembrane pressure of the probes and the relative recovery. This will be addressed on chapters 3 and
4. By assuming that the pressure applied to the microdialysis sampling probe or hydraulic pressure (flow
rate) is constant, we could measure the pressure change during in vivo experiments.
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In other words, the pressure change would be the difference between the hydraulic pressure and the
pressure outside the microdialysis sampling probe. Regulating this pressure change systematically could
lead to higher relative recoveries.
Microdialysis probes in series
Microdialysis probes in series is a new approach that was developed during this dissertation to
improve the relative recovery of biomolecules during microdialysis sampling and toward eliminating the
need for microdialysis sampling calibration methods. Microdialysis probes in series approach optimizes
membrane surface area and perfusion fluid residence time to increase relative recovery of macromolecules.
As far as the author know nobody has done something similar. The new approach consisted of up to four
microdialysis probes in series, see Figure 1.16.

Figure 1.16. Four microdialysis probes in series system.

As far as this author knows there are not similar work published in the scientific literature. However,
there is a patent65 similar to the work of this dissertation. The aims of this dissertation and the patent were
different, since four microdialysis probes were not going to be implanted in any living system. It is good to
point out that this dissertation work was used to assess the difference between theory and experiment.
Previously researchers have implanted four microdialysis probes in living systems in order to assay a larger
sampling area and closely monitor concentration changes of biomolecules. This is done to have a higher
resolution of concentration changes in a sampling area.
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For example, Wei et al. implanted four microdialysis probes in the heart of dogs to study the enzymatic
mechanism of angiotensin II in the interstitial fluid. Another example was the work done by Strouch et al.
They implanted four CMA/20 microdialysis probes subcutaneously in swine to study the extracellular cyclic
adenosine monophosphate.66 It is good to point out that these microdialysis probes in both of those studies
were not connected in series or parallel. Samples were taken from them independently. Wei’s and Strouch’s
groups wanted to map the concentration of their analyte by using multiple microdialysis probes. The
problem of implanting multiple microdialysis probes in any living system is the amount of damage that it
causes to the tissue from which samples are been taken. Nevertheless, if the concentration changes of a
biomolecule want to be studied in any organ, more than one microdialysis probe could be used to cover a
larger area. Finally, Lu and colleagues glued four probes together to be implanted and used to sample
biomolecules, see Figure 1.17. Their work showed that microdialysis probes could be arrayed in series and
parallel.65 The four microdialysis probes in series approach was used as the basis to develop a
polydimethylsiloxane (PDMS) microfluidic-based microdialysis probe.
Microfluidic devices used or applied to microdialysis sampling
Manufacture of microfluidic devices is emerging as one the fastest growing research areas. 67 It is
estimated that this year (2016), pharmaceutical & biomedical research will use $1 billion worth of
microfluidic devices. The microfluidics market is expected to reach $4 billion this year. 68 The combination
of microfluidic devices and microdialysis sampling in order to develop a diagnostic system able to monitor
in real-time concentration changes of biomolecules and make faster diagnosis, unlike traditional methods,
during disease states is needed. Researchers have developed different approaches to tackle this need.
Finally, the number of publications related to microfluidics and membranes have had a substantial growth
since 1996, see Figure 1.18.69
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Figure 1.17. Four microdialysis probes approach by Lu et al.65

Figure 1.18. Growth in the number of publications related to microfluidic and membranes. 69 Reproduced
from reference 69 with permission of The Royal Society of Chemistry.
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1.6.1

Microfluidic devices based on microdialysis sampling
Miniaturization
There is a growing interest in miniaturizing microdialysis sampling technique into microfluidic

systems.70,

71, 72

The advantages of achieving this are: a) Significant reduction in cost, b) smaller sample

volume, and c) faster results. On other hand, according to Tüdős et al., “The large ratio of volume and flow
rate between the microfluidic components and their associated conventional fluidics raises considerable
system integration challenges when miniaturised devices are incorporated into instrumentation.”70 That is
while the growing interest in miniaturizing microdialysis sampling into microfluidic systems and microfluidics
in general, has created a need for engineering fundamental work. 70 Some of the engineering tools used to
develop microfluidics are summarized in Table 1.5.70 One of these tools is dialysis, used to separate
biomolecules as previously mentioned in this chapter.
Since microdialysis sampling technique requires a membrane to allow the separation of analytes
from complex matrices, choosing the appropriate fabrication approach is crucial for a successful microfluidic
device. An in-depth review about membranes and microfluidics has been provided by de Jong et al. 69
They divided several fabrication approaches used to integrate membranes in microfluidic systems into four
categories, see Table 1.6.69 1) Direct incorporation of (commercial) membranes, 2) membrane preparation
as part of the chip fabrication process, 3) in-situ preparation of membranes, and 4) use of membrane
properties of bulk chip material were the four categories developed by de Jong and colleagues.69
Table 1.5. Summary of engineering tools used for microfluidics. 70 Reproduced from reference 70 with
permission of The Royal Society of Chemistry.
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Table 1.6 shows more details about their categories. For the work done for this dissertation, the category
one was used. To explain, commercially available polyethersulfone (PES) membranes were used to make
the devices. PES was the membrane material of choice, since microdialysis probes having PES
membranes were used. Chapter 5 is going to cover this in more detail. Finally, de Jong et al made a useful
flow chart to help researchers choose membranes and fabrication approaches suitable for their needs, see
Figure 1.19.69
Microfluidic microdialysis devices
Several researchers have designed and developed microdialysis devices to sample or monitor
biomolecules. For instance, Hsieh and Zahn devised a microfluidic microdialysis biochip for glucose
recovery.71 They engineered an in vitro on-chip microdialysis system to study concentration changes of
glucose. The key feature of their design was that for the microdialysis probe membrane they used thin-film
fabrication technique and direct polymer bonding giving them a more efficient microdialysis system. This
was due to the fact that high surface to volume ratio can be achieved with these techniques. 71
Subrebost developed a similar microfluidic system for his PhD dissertation. 73 Subrebost’s system
consisted of a membrane at the tip of an a silicon chip. His device has an on-chip fraction collector and
embedded platinum planar electrodes used as a membrane biofouling control. 73 However, Subrebost
system was designed, but never tested experimentally.
Recently, Lee et al. published a work showing a new method to microfabricate microdialysis probes
in silicon.74 They were able to fabricate a microdialysis probe 79% smaller (160 µm) than the smallest
conventional microdialysis probes’ cross-sectional area, see Figure 1.20.74 Lee and colleagues used a flow
rate of 100 nL/min (0.1 µL/min).74 As previously stated in this chapter and they stated in their conclusions,
such as small flow rates are a drawback.
The main difference between Subrebost’s design and this dissertation’s design was that
Subrebost’s design focused on membrane biofouling. The design outlined in this dissertation was focused
on miniaturizing the microdialysis probes in series approach. An approach developed to eliminate the need
for microdialysis sampling calibration methods.
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Table 1.6. Division of fabrication approaches by de Jong et al’s.69 Reproduced from reference 69 with
permission of The Royal Society of Chemistry.
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Figure 1.19. Flow chart for membrane and fabrication selection made by de Jong et al. 69 Reproduced from
reference 69 with permission of The Royal Society of Chemistry.
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Figure 1.20. Lee at al. small microdialysis probe.74 Reprinted with permission from reference 74. Copyright
2017 American Chemical Society.

Hsieh and Zahn mentioned above, developed another device in 2007 to monitor glucose on a
polydimethylsiloxane (PDMS) microfluidic system.71 Their microdialysis on-a-chip system used platinum
electrodes to measure the glucose concentration and a micromixer to avoid concentration gradients due to
not well-mixed flows. Microdialysis type microfluidic systems have also been used for protein
preconcentration. Kim et al. devised a microfluidic dialysis system to enrich protein samples by modifying
the dialysis membrane with oxygen plasma.75They modified the dialysis membrane using oxygen plasma
treatment to change the hydrophobicity of the membrane surface to improve flux and selectivity. They made
serpentine channels on two PDMS substrates. These two PDMS substrates were used to sandwich a
regenerated cellulose membrane. Fluid flows from either side of the microfluidic system.
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The microfluidic system that was developed for this dissertation could be another step toward
eliminating the need for microdialysis sampling calibration methods, due to the fact that the microdialysis
probes in series approach was able to achieve ~100 % recovery of small molecules such as methyl orange
in in vitro experiments. This means that the concentration of analyte collected would be approximately the
same as the concentration in the sampling site, ideally, and microdialysis sampling calibration methods
would not be necessary. Eliminating microdialysis sampling calibration methods, would be one of the
greatest achievement of the field, if reached.
The PDMS microfluidic device was developed by miniaturizing the microdialysis probes in series
method, see Figure 1.16. An external pump and analytical benchtop detection methods still need to be used.
The main aim was to make a microdialysis probe-like device better, in terms of recovery, than the current
commercially available. The idea was to mimic the four microdialysis probes in series approach by having
four channels connected in series, but parallel to each other, see Figure 1.21. The number of probes required
to achieve ~100% relative recovery of methyl orange was determined in vitro. A mathematical model based
on Bungay’s and Jacobson’s work was devised to estimate the number of microdialysis probes in series
necessary to achieve ~100% recovery of methyl orange and isothiocyanate-dextrans (FITCs), see Equation
1.6. By translating the number of probes necessary to achieve ~100% recovery of any analyte into number
of channels, the microfluidic device could be tailored for wide range of biomolecules based on their mass
transfer coefficient (k), see Equation 1.6. From a practical standpoint, this would be more like a calibration
of the device. For example, several biomolecules could yield ~100% recovery for the same number of
channels.
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Figure 1.21. 3D model of the microdialysis in series microfluidic device engineered for this dissertation.
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Chapter 2. Proof of principle recycling flow approach using 100 µM methyl orange solution
Background and Significance
This chapter describes the work that was performed to demonstrate that a recycling flow approach

could be used to improve relative recovery of small molecules during microdialysis sampling experiments.
Methyl orange, a small molecule of 330 Da was used as the analyte. A solution of 100 µM methyl orange
in high performance liquid chromatography (HPLC) grade water was used. The availability and cost of
methyl orange made it an ideal analyte for this work. The recycling flow experiments described in this
chapter laid the foundation of the microdialysis probes in series approach. A detailed description of the
microdialysis probes in series approach is covered in chapter 3. Experiments were conducted to evaluate
the number of microdialysis probes in series necessary to achieve ~100% relative recovery. The
experiments were performed under quiescent and stirred conditions. The main purpose was to study the
influence of flow rate and number of cycles on relative recovery.
Experimental section
A solution of 100 µM methyl orange (Sigma-Aldrich, St. Louis, MO) in HPLC grade water was used
as the target analyte. A 0.6 mL plastic reservoir was used to place the microdialysis probe. The microdialysis
probe used was a CMA/20 microdialysis probe having a 10-mm polyethersulfone (PES) membrane of 100
kDa molecular weight cutoff (MWO) (Harvard Apparatus, Holliston, MA), see Figure 2.1. A MAB-20
microdialysis pump was used to recycle the dialysate through the probe (Microbiotech, Stockholm,
Sweden), see Figure 2.2. HPLC grade water was used as perfusion fluid. One cycle was defined as one
dialysate or sample collection. This was equivalent to collections conducted during regular microdialysis
sampling. The first dialysate collected was used as perfusion fluid for the second collection, the second
dialysate collected was used as perfusion fluid for the third collection, and so on, see Figure 2.3. The
experiments were performed under quiescent and stirred conditions see Figure 2.2 and Figure 2.4. The
bulk of the experiments were performed under quiescent conditions. The flow rates used for the recycling
flow microdialysis experiments under quiescent condition were 0.8, 1.0, 2.5, and 5.0 µL/min. A flow rate of
2.5 µL/min was used for the recycling experiments performed under stirred (on a stir plate at 800 rpm)
condition and a maximum of 5 cycles, see Figure 2.5.
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Figure 2.1. CMA/20 microdialysis probe of 100 kDa and PES membrane of 10 mm in length used for the
experiments.

Figure 2.2. Recycle flow set up used for microdialysis experiments conducted under quiescent condition
using MAB-20 pump.
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Figure 2.3. Set up used to recycling flow experiments. Point a) HPLC grade water reservoir (perfusate).
Point b) 100 µM methyl orange solution or analyte. Point c) Collection vial (dialysate).

Figure 2.4. Recycle flow set up used for microdialysis experiments conducted under stirred condition using
MAB-20 pump.
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Figure 2.5. Comparison of relative recovery (RR) of 100 µM methyl orange under quiescent and stirred
conditions during microdialysis recycling flow experiments using a 100 kDa CMA/20 microdialysis probe
having a 10 mm PES membrane in length, 5 cycles. HPLC water was used as perfusion fluid at 2.5 µL/min.
n = 3, *n = 2, and average ± standard deviation

The maximum number of cycles used for the collections of methyl orange under quiescent condition was
four for 0.8, 1.0, and 5.0 µL/min, and five and ten cycles for 2.5 µL/min, see Figure 2.5, Figure 2.6, and
Figure 2.7. The absorbance of each dialysate was measured at a wavelength of 466 nm using a
TecanSpectraFluor plate (96 wells) reader (Tecan Group Ltd., Männedorf, Switzerland) and was compared
vs. a calibration curve. At least 50 µL of dialysate was required for measurement with the plate reader.
Three aliquots were taken from each dialysate and each one was diluted to 100 µL in HPLC grade water.
Results and discussion
A logarithmic relationship between flow rate and the number of cycles was found for the recycling
flow experiments, see Figure 2.6 and Figure 2.7. This finding is in line with what has been previously
reported in the literature by Lerma et al.1 The highest relative recoveries for methyl orange using recycling
flow were obtained at 0.8 µL/min and 4 cycles (100.3%) and 2.5 µL/min and 9 cycles (98.1% ± 2.7%), see
Figure 2.7. These results show the tradeoff between flow rate and number of cycles.
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Figure 2.6. Relative recovery (RR) of 100 µM methyl orange under quiescent conditions collected during
microdialysis recycling flow experiments at 2.5 µL/min, 10 cycles. HPLC water was used as perfusion fluid.
n = 3 and average ± standard deviation. The red line shows the 100% RR region.

Figure 2.7. Relative recovery (RR) of 100 µM methyl orange using recycling flow method under quiescent
condition. HPLC water was used as perfusate at different flow rates.
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This was expected for a diffusion-based technique such as microdialysis. The residence time or the time
analyte stays in contact with the perfusion fluid across the membrane/sample interface, increases at lower
flow rates. Lower flow rates allow more time for methyl orange to diffuse through the microdialysis
membrane and be carried by the perfusion fluid. Therefore, fewer cycles are needed as compared to higher
flow rates. Higher flow rates require more cycles to increase the residence time. For the experiments
conducted under stirred condition the relative recovery of methyl orange as a function of the flow rate was
higher (83.9% ± 0.6%) compared to the quiescent experiments (68.5% ± 4.9%), see Figure 2.5. This is due
to the fact that the mass transport resistance of the quiescent medium external to the microdialysis probe
(Rq) approaches zero in well-stirred solutions reducing its influence on the relative recovery (see Equation
1.2 in chapter 1). The problem with collecting 50 µL was that it significantly increased the amount of time
necessary to conduct an experiment due to the experimental set up chosen. As can be seen on Table 2.1
~8 hours and 20 minutes were needed to conduct one set of experiments for one flow rate. This was
necessary to conduct the five-cycle’s experiments. The rinse time was determined by measuring the time
that the perfusion fluid took from the reservoir to the collection vial (from point “a” to point “c”), see Figure
2.3. The set up was chosen in order to have more control over each individual cycle. To reduce time, sample
volume, and cost, a different approach was developed. The flow rates used for the microdialysis in series
approach experiments, chapter 3, were based on the results obtained on this chapter. The new approach
consisted of several microdialysis probes in series.

Table 2.1. Sequence used for the collection of 100 µM methyl orange at 2.5 µL/min.
Cycle #

Calculated collection volume (µL)

Collection time (min)

1

450

180

2

350

140

3

250

100

4

150

60

5

50

20

Notes: The calculated collection volume was calculated by multiplying the flow rate times the collection
time.
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Chapter 3. In vitro collection of methyl orange and fluorescein isothiocyanate-dextrans (FITCs)
using microdialysis probes in series
Introduction
A new microdialysis sampling method was developed to reduce the amount of time, sample

volume, and cost required to perform the recycling flow experiments (Table 2.1). The new approach
consisted of two microdialysis probes in series, see Figure 3.1 and Figure 3.2. The number of microdialysis
probes connected in series was extended to four probes, see Figure 3.3. Four microdialysis probes was
the maximum number probes in series that was tested for this work. The method was called microdialysis
probes in series due to the fact that microdialysis sampling probes were connected in series. To evaluate
the probes in series method two set ups were used. The reservoir where the microdialysis probes in series
were placed went through different iterations. This was done to minimize the volume of analyte needed for
the experiments. In this chapter, the was to demonstrate in vitro microdialysis probes in series approach
for a series of compounds with a wide-range of molecular weight (methyl orange, FITC-4, FITC-10, FITC20, and FITC-40). This work serves as a proof of principle for next generation microdialysis probe. The
latter will be addressed in chapter 5 in detail.

Figure 3.1. Microdialysis probes in series method having each probe in separate vials (two probes), 0.6
mL plastic vials.
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Figure 3.2. Microdialysis probes in series method having the probes in the same vial (two probes), 20.0
mL house-made reservoir.

Figure 3.3. Microdialysis probes in series method having the probes in the same vial (four probes).
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Experimental section
3.2.1

Proof of principle and initial settings
The microdialysis probes in series approach went through a series of iterations as mentioned

before, see Table 3.1. This was done to reach the optimal settings of the method for future experiments
using proteins. The first set of iterations consisted of two and four microdialysis probes in series, see Figure
3.1, Figure 3.2, and Figure 3.3. These probes were either placed in separate reservoirs or in the same
reservoir. A CMA 110 liquid switch from Harvard Apparatus, Holliston, MA was used as tubing holder to
facilitate the connections between probes, see Figure 3.4. The MAB-20 pump previously used for the
recycling flow experiments, chapter 2, was replaced by a BASi syringe pump system (West Lafayette, IN).
Microdialysis probes (CMA/20) of 100 kDa molecular weight cutoff (MWCO) and 10 mm polyethersulfone
(PES) membrane were from Harvard Apparatus (Holliston, MA). The absorbance of each dialysate was
measured at a wavelength of 466 nm using a TecanSpectraFluor plate (96 wells) reader (Tecan Group
Ltd., Männedorf, Switzerland) to determine their concentration using an appropriate calibration curve.

Table 3.1. Iterations performed to the microdialysis in series approach.
Iteration
Perfusion
Settings
Instrument
#
fluid
Two probes in
TecanSpectraFluor
separate vials.
plate reader
Two and four
requiring sample
1
HPLC water
probes in
volume of ≥ 50 µL.
same
Samples were
reservoir.
diluted.
NanoDrop 2000
requiring sample
2
Same
Same
volume of 2 µL.
Samples were not
diluted
4% dextran-70
or 0.1% BSA in
3
Same
Same
10 mM PBS pH
7.4

4

Same

4% dextran-70
in 10 mM PBS
pH 7.4

Same

Reservoir
0.6 mL vials for probes
placed separate and 20.0 mL
house-made container for
probes placed together using
Parafilm M® and a plastic lid.

Same

0.6 mL vials for probes
placed separate and 5.0 mL
house-made plastic vial for
probes place together.
0.6 mL vials for probes
placed separate and ~2.5 mL
house-made plastic vial
wrapped with aluminum foil
for probes place together
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Figure 3.4. Four microdialysis probes in series in the house-made ~2.5 mL reservoir showing aluminum
paper for light protection.

At least 50 µL of dialysate was required in order to measure the concentration of methyl orange samples
using the plate reader. Three aliquots were taken from each dialysate and each one dilute to 100 µL in
HPLC grade water.
For this set of iterations, a solution of 100 µM methyl orange in HPLC grade water was used as the analyte.
A house-made reservoir was built to hold the microdialysis probes in the same container. The reservoir was
made out of a plastic lid and Parafilm M®, see Figure 3.2 and Figure 3.3. The volume of the reservoir was
20.0 mL. The reservoirs used for the microdialysis probes placed in separate reservoirs were clear plastic
microvials of 0.6 mL. Collections of two independent microdialysis sampling experiments, regular
microdialysis, were added. This was done to compare the relative recovery of two probes in series in
separate and same reservoir versus adding the relative recoveries of two probes from separate
microdialysis experiments. The flow rate used for these experiments was 2.5 µL/min. For the next iteration
a NanoDrop 2000 UV-Vis spectrophotometer from Thermo Scientific (Wilmington, DE) was used to
measure the absorbance of the dialysates. The advantage of using the NanoDrop is that it only requires 2
µL of sample volume, reducing significantly the sample size and collection time. From this point forward, all
experiments were conducted using the NanoDrop unless otherwise stated.
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For these experiments 100 µM methyl orange solution was used as the analyte and HPLC water as the
perfusion fluid. The flow rates used were 1.0, 1.5, 2.0, 2.5, 3.0, and 4.0 µL/min. The 20.0 mL plastic reservoir
was used.
After several experiments performed using HPLC water as the perfusion fluid, the chemical
composition of the perfusion was changed to match the composition of the extracellular fluid. The chemical
or ionic composition of the extracellular fluid is: Sodium 0.142 mol, potassium 0.005 mol, calcium 0.002
mol, magnesium 0.001mol, chloride 0.105 mol, bicarbonate 0.024 mol, and phosphate 0.0007 mol.1, 2 This
is commonly used to maintain appropriate osmotic pressure and ionic composition. Also, it is used to
minimize the level of disturbance of biology in living systems during microdialysis sampling collections
performed in vivo. The perfusion fluid used for the in vitro experiments was a solution of 10 mM phosphate
buffered saline (PBS) pH = 7.4 having either 4% (w/v) dextran-70 or 0.1% (w/v) bovine serum albumin
(BSA) from Sigma-Aldrich, St. Louis, MO. It is good to point out that for this dissertation in vivo experiments
were not conducted. The PBS used for this dissertation was composed of 10 mM disodium phosphate, 1.8
mM monopotassium phosphate, 2.7 mM potassium chloride, and 137 mM sodium chloride. Calcium
chloride dihydrate and magnesium chloride hexahydrate are supplemented in some applications such as
in vivo experiments.3 The objective of adding dextran-70 and BSA was to evaluate how these osmotic
agents would influence the relative recovery of methyl orange.4, 5
The flow rates used were 1.0, 2.5, and 5.0 µL/min. HPLC water was used as control. Previously, Parafilm
M® was used to hold the microdialysis probes connected in series for the 20.0 mL plastic reservoir. The
problem with using this is that it is very fragile and tends to give away. A new 5 mL reservoir able to hold
four microdialysis probes firmly was made for these experiments. One of the aims of this iteration was made
to reduce the volume of the reservoir from 20.0 mL to 5.0 mL.
The last iteration was made to the microdialysis in probes in series approach. This was done to
further reduce the volume of the reservoir from 5 mL to ~2.5 mL. Aluminum foil was used to minimize the
interaction of light and the analyte in the reservoir of ~2.5 mL, see Figure 3.4. All experiments done using
this reservoir used aluminum foil unless otherwise stated. By reducing the volume of analyte in the reservoir,
more expensive compounds could be used to further evaluate the microdialysis probes in series method.
51

The idea was to eventually use the method to collect proteins such as cytokines. It is good to point out that
proteins were not used for this dissertation.
3.2.2

Four microdialysis probes in series
For this last iteration, four microdialysis probes in series, a set of experiments were conducted.

Solutions of 100 µM methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40 were prepared in 10 mM
phosphate buffered saline (PBS) pH = 7.4. The perfusion fluid used for the experiments was 10 mM (PBS)
pH = 7.4 having 4% dextran-70 as osmotic agent commonly used in microdialysis experiments to reduce
fluid loss and “counterbalance the transmembrane hydrostatic driving pressure”. 4 All the chemicals used
were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise stated. BASi syringe pumps and
gastight 1.0 mL syringes were used (Bioanalytical Systems Inc., West Lafayette, IN). Microdialysis probes
(CMA/20) of 100 kDa molecular weight cutoff (MWCO) and 10 mm polyethersulfone (PES) membrane were
used. The idea behind these experiments was to obtain detailed information about the relationship between
recovery, number of probes in series (i.e., 1, 2, 3, and 4), flow rate, and molecular weight. Probes were
connected to each other in series without altering the standard tubing lines (200 mm length and 0.12 mm
internal diameter inlet and outlet lines) that comes with the CMA/20 dialysis probes. For the number of
probes in series the collection through one or a single microdialysis probe was used a control. This was
chosen because one microdialysis probe is commonly used during microdialysis sampling experiments.

Figure 3.5. Schematic representation of microdialysis probes in series approach.
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The same experiments were conducted having two, three, and four microdialysis probes in series. Figure
3.5 shows a schematic representation of the new four microdialysis probes in series approach. Flow rates
of 0.8, 1.0, and 1.5 µL/min were used.
A simple and straightforward procedure was developed: a) Perfuse perfusion fluid (PBS) for ~15
min or until dialysate absorbance was within 5% relative standard deviation (RSD), measurements were
performed in triplicate unless otherwise stated, b) measure the absorbance of the outside solutions or
solutions place in the in-house made plastic container before changing to a new flow rate, and c) after
changing flow rates flush the system for the same amount of time and criteria than “a” to avoid cross
contamination from one flow rate to another.
Results and discussion
3.3.1

Proof of principle and initial settings

Figure 3.6 shows the relative recoveries of 100 µM methyl orange collected using two microdialysis
probes either in series or individually. According to these preliminary results the relative recovery of methyl
orange was higher (46.0% ± 1.7%, n=3) when microdialysis probes were connected in series and placed
in the same reservoir than when they were placed in separate reservoirs (36.1%, n=2). This could be due
to fluid loss having a greater impact or diluting the methyl orange in a smaller reservoir (0.6 mL) than in the
larger reservoir (20.0 mL) used to place the two probes together.
As comparison, relative recovery of methyl orange was determined using two microdialysis probes.
To explain, the relative recoveries were added together, and the total was used to compare it to the two
probes in series. These two microdialysis probes were not connected in series, but regular microdialysis
sampling experiments were performed on both. The relative recoveries of these microdialysis probes were
26.0% ± 1.3%, n=3 and 22.2% ± 1.1%, n=3 respectively. The total relative recovery of these probes was
48.2% ± 1.7%, n=3. The fluid loss and transmembrane pressure of two probes in series is significantly
different than having two separate microdialysis probes. Fluid loss will be address in more detail later in the
chapter. When four microdialysis probes were connected in series a relative recovery of 100.8% ± 2.4%,
n=3 was obtained for methyl orange at a perfusion fluid flow rate of 1.0 µL/min.
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The outside solution was under quiescent condition and HPLC water was used as perfusion fluid without
any osmotic agents. Compared to the recycling flow method relative recoveries obtained under similar
conditions, the four microdialysis probes in series relative recoveries were higher, see Figure 3.7. For
example, the methyl orange relative recovery using four probes in series at a perfusion rate of 2.5 µL/min
was 83.9% ± 1.3%, n=3 and the methyl orange relative recovery using recycling flow (four cycles) at the
same rate was 75.0% ± 0.3%, n=3. These results are a good indication of the benefits of adding
microdialysis sampling probes in series for small molecules. Nevertheless, the opposite effect was found
for large molecules such as FITC-40. For larger molecules the fluid loss is the critical factor influencing
relative recovery. This will be addressed in the four probes in series discussion, section 3.3.2.
Several perfusion fluids of different chemical compositions were tested using a reservoir of 5 mL to
hold the microdialysis probes in series more firmly. The results are shown on Figure 3.8. The perfusion fluid
that yielded the highest relative recovery of methyl orange was 4% dextran-70 in 10 mM PBS. For instance,
the relative recovery of methyl orange using this perfusion fluid at 2.5 µL/min was 94.0% versus the control,
HPLC water, 80.1%. These results are in agreement with what is found in the literature on regular
microdialysis sampling, even though the transmembrane pressure in the microdialysis in series approach
is higher.6, 7
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Figure 3.6. Relative recovery (RR) of 100 µM methyl orange in HPLC water using two microdialysis probes
in series in the 20.0 mL reservoir under different settings at 2.5 µL/min. (Control = Avg. Pr-1 & Pr-2). n = 3,
*n = 2, and average ± standard deviation.
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Figure 3.7. Comparison of relative recovery (RR) of 100 µM methyl orange using microdialysis recycling
flow and four probes in series method at different flow rates. Four cycles and four probes in series were
used during the experiments (20 mL reservoir for probes in series). n = 3 and average ± standard
deviation.

According to Li et al., “To minimize fluid loss from the probe due to osmotic effect, the osmolarity
of the perfusate is often adjusted to balance the physiological osmolarity by adding osmotic agents, e.g.
dextran-70 or a protein such as bovine serum albumin (BSA).”6 Regulating the transmembrane pressure or
fluid loss across microdialysis probe membranes is vitally important during microdialysis sampling
experiments, especially during in vivo experiments.
3.3.2

Four microdialysis probes in series
Figures 3.9, 3.10, and 3.11 show the relative recoveries of FITCs and methyl orange collected

using one, two, three, and four probes at different flow rates (0.8, 1.0, and 1.5 µL/min), respectively. These
results show that the relative recovery significantly improves as the number of probes in series increases.
For instance, if the collections of methyl orange at 0.8 µL/min for one probe or control (regular microdialysis)
(66.7 ± 4.6 %, n=3) and four probes (99.7 ± 1.0 %, n=3) are compared, you can see the significant
improvement on the recovery (~33%). However, when we compared the recoveries of two probes versus
three probes, and three probes versus four, the improvement was not as significant (~4%), see Figure 3.9.
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Figure 3.8. Relative recovery (RR) of 100 µM methyl orange under different perfusion fluid chemical
compositions and flow rates using 5.0 mL reservoir and four probes in series method.

This could be explained by the size and diffusion properties of methyl orange (330 Da, and a high mass
transfer coefficient, kA, of ~0.9 µL/min). For one probe the surface area of the system is at its minimum,
but the concentration gradient is higher. As the number of probes increases the surface area becomes
larger (greater residence time) increasing recovery, but decreasing concentration gradient. Since the
probes are in series, the dialysate of one probe becomes the perfusate of the probe attached to it. As a
result, the concentration gradient decreases due to the presence of a non-zero analyte concentration inside
the probe (membrane) relative to the outside. That is why after two probes in series there is a steady
increase in recovery rather than a sharp one. Another factor that could play a role in this behavior is osmotic
pressure or fluid loss. For example, the fluid losses measured during microdialysis probes in series
approach experiments using 100 µM methyl orange as the analyte were as follows: 1) One probe or control
+8.40% (gained fluid), 2) two probes in series -1.30%, 3) three probes in series -11.40%, and 4) four probes
in series -28.40%. The fluid losses were quantified by measuring the amount of dialysate collected over a
set period of time and relating this to the pumping flow rate. For instance, collections conducted at a
pumping flow rate of 5.0 µL/min for 2 min would yield a dialysate volume of 10.0 µL, if not fluid loss or gain
was present.
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Thus, if fluid loss was present and the dialysate measured volume was 7.0 µL, it would yield a fluid loss of
-30% for FITC-4, see Figure 3.9, the change in recovery from one probe to four probes at 0.8 µL/min was
~32% (34.1% vs. 66.3%) and after two probes in series the difference was ~11%.
Overall the change in relative recovery from one probe to four probes was follows: a) Methyl orange
~33%, b) FITC-4 ~32%, c) FITC-10 ~17%, d) FITC-20 ~4%, and e) FITC-40 ~2%. It is good to point out
that even though the change in recovery for methyl orange and FITC-4 were similar, their relative recoveries
were different for one probe and four probes. These results show how molecular weight not only affects
recovery, but also the diffusion behavior of molecules across a membrane. For larger molecules the
increase in relative recovery as the surface area increases is linear as compared to smaller molecules
logarithmic, see Figures 3.9, 3.10, and 3.11. This is because as the concentration of molecules increase
(for a fixed period of time), for larger molecules, inside the microdialysis probe membrane, the movement
of them decreases. In other words, there are more molecules colliding into each other to move from outside
the membrane of the probe to the inside, reducing the relative recovery. This is known as concentration
polarization.
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Figure 3.9. Relative recoveries (RR) of 100 µM methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40 at
0.8 µL/min flow rate using probes in series. One probe on the above graph represents the control or regular
microdialysis and two, three, and four probes represent probes in series respectively. (*) Denotes a oneway ANOVA (p<0.05) showed a statistically significant difference among control and probes RR. n = 3 and
average ± standard deviation.
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Figure 3.10. Relative recoveries (RR) of 100 µM methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40
at 1.0 µL/min flow rate using probes in series. One probe on the above graph represents the control or
regular microdialysis and two, three, and four probes represent probes in series respectively. (*) Denotes
a one-way ANOVA (p<0.05) showed a statistically significant difference among control and probes RR. n =
3 and average ± standard deviation
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Figure 3.11. Relative recoveries (RR) of 100 µM methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40
at 1.5 µL/min flow rate using several probes in series. One probe on the above graph represents the control
or regular microdialysis and two, three, and four probes represent probes in series respectively. (*) Denotes
a one-way ANOVA (p<0.05) showed a statistically significant difference among control and probes RR. n =
3 and average ± standard deviation
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Another factor that could be playing a role on how the relative recovery of larger molecules
increases as a function of adding microdialysis sampling probes in series (increasing surface area) is the
mass transfer coefficient (k). Mass transfer coefficient is a rate constant for molecules moving from the
boundary to the bulk per area.8This is commonly used in engineering to analyze diffusion processes. When
k is large, a faster mass transfer is taking place. On the other hand, when k is small the mass transfer is
slower.8 There is an inverse exponential relationship between molecular weight and k for the CMA/20
microdialysis probe used, see Figure 3.12. These values were determined experimentally in order to
estimate how many probes were needed to achieve nearly 100% recovery using this system. The latter will
be addressed in detail in chapter 4. To sum up, increasing the number of probes in series (up to 4 for methyl
orange) or surface area significantly improves relative recovery and it is limited by the pore size or MWCO
of the microdialysis probe.
To determine if a greatly reduced convective force would increase the relative recovery for
increased probes, we set up a recycled microdialysis sampling system with a peristaltic pump. As previously
mentioned in section 3.3.1, for small molecules (330 Da) such as methyl orange the relative recovery during
microdialysis probes in series experiments were higher than recycling flow method, see Figure 3.7.
However, the opposite was true for large molecules (FITC-40, 40 kDa), see Figure 3.13. This could be due
to the mass transfer differences between methyl orange (kA~0.9 µL/min) and FITC-40 (k~0.05 µL/min).
The relative recovery of FITC-40 using the recycling flow method for four cycles was almost two times
higher than the relative recovery of FITC-40 during four probes in series experiments. During recycling flow
experiments the fluid loss is minimal, since the same fluid is recirculated in one microdialysis probes. Methyl
orange is approximately eighteen times faster than FITC-40. This allows methyl orange to overcome the
opposition to move from outside the microdialysis probes membrane to the inner part caused by fluid loss.
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Solutes and their molecular weights
Figure 3.12. Relationship between molecular weight (MW) and mass transfer coefficient (kA) for a CMA/20
microdialysis probe. Each bar represents one solute and one set of experiments.
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Figure 3.13. Comparison of the relative recovery (RR) of 100 µM FITC-40 using the recycling flow and the
probes in series method at 1.0 µl/min. The perfusion fluid was 4% dextran-70 in 10 mM PBS pH = 7.4. n =
3 and average ± standard deviation.
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Conclusion
An in vitro method consisting of four microdialysis probes in series to determine the needed number
of probes for the collected dialysate to reach near equilibrium with the solute concentration was devised.
This method significantly improved the recovery of methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40
without the need of using slow flow rates (< 0.5 µL/min). This work may serve as a basis for the development
of a programmable microfluidic system for the collection of biomolecules.
Additionally, one could envision using this approach to get an estimate of in vivo concentrations
and use it periodically within experimental runs to verify in vivo concentrations. To continuously run with
multiple probes will certainly reduce temporal resolution, but again it could be used at the start and
completion of an in vivo experiment to gain important information about biological concentrations, without
using the cumbersome in vivo calibration methods for microdialysis sampling described in the literature.

63

References
1. http://chemistry.elmhurst.edu/vchembook/250fluidbal.html.
2. http://www.slideshare.net/mvraveendrambbs/body-fluid-and-electrolyte-balance.
3. http://cshprotocols.cshlp.org/content/2006/1/pdb.rec8247.
4. Zhou, Q. Y.; Gallo, J. M., In vivo microdialysis for PK and PD studies of anticancer drugs. Aaps Journal
2005, 7 (3), E659-E667.
5. Tsai, T.-H., Applications of microdialysis in pharmaceutical science. John Wiley & Sons: 2011.
6. Polak, J. M., Advances in tissue engineering. Imperial College Press: 2008.
7. Stenken, J. A., Methods and issues in microdialysis calibration. Anal. Chim. Acta 1999, 379 (3), 337357.
8. Cussler, E. L., Diffusion: mass transfer in fluid systems. Cambridge university press: 2009.

64

4

Chapter 4. Recovery estimations of methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40
using a modified version of Jacobson et al. linear regression method and Bungay’s
mathematical model for microdialysis sampling
Introduction
After demonstrating that the microdialysis sampling probes in series approach improves the relative

recovery of methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40, a mathematical method to estimate
how many probes or microchannels are needed to achieve ~100% recovery was derived.
Jacobson et al. pointed out that the mass transfer coefficient (k) of any molecule can be determined
experimentally during microdialysis sampling by measuring its recovery at different flow rates and plotting
the results to find the slope (kA) using the following approach:1 a) Since 𝑘A(n) = (

1

Rd + Rm +Rq

) , Equation

1.4, where A is surface area of the probe and n is the number of probes, b) Equation 1.2 (Bungay’s
−1

equation2), RR = 1 − exp {

} ,combining “a” and “b” to get c) Equation 1.5, RR = 1 −

Qd (Rd +Rm +Rq )

exp (

−𝑘A(n)
Qd

), and rearranging “c” we obtain d) 𝒌𝐀(𝐧) = [−𝐥𝐧(𝟏 − 𝐄𝐄)]𝐐𝐝 , Equation 1.6. This equation can

be used if (1-RR) ≠ 0. By plotting –ln(1-RR) vs. Qd-1 the values of kA or the slope regardless of the surface
area were obtained, see Figure 4.1.
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y = 0.0483x - 0.0002
R² = 0.9996
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Figure 4.1. Estimation of kA for FITC-40 using Equation 1.6 and Jacobson’s approach.1
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The value of kA was determined for methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40. This was done
by calculating their relative recoveries using one microdialysis probe at different flow rates (0.8, 1.0, 1.5
µL/min) and plotting the results, see Figure 4.1. The mass transfer coefficient, kA, of each compound was
determined experimentally using a CMA/20 microdialysis probe. Then kA was multiplied by n or the number
of probes to estimate the recoveries using Equation 1.6. These estimations were compared to the
experiments conducted on Chapter 3.
Results and discussion
The theoretical estimations agreed with the experiments for methyl orange, Figure 4.2, and FITC-4,
Figure 4.3. For example, the deviation from experiments of methyl orange was -1% (underestimation) and
+15% (overestimation) for FITC-4 using four probes in series at 0.8 µL/min. However, the theoretical
estimations started deviating from experiments at a molecular weight of ~10,000 (FITC-10). The deviation
from experiments using four probes in series at 0.8 µL/min for FITC-10 (Figure 4.4), FITC-20 (Figure 4.5),
and FITC-40 (Figure 4.6) were +52%, +149%, and +179% respectively.
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Exps. at 1.0 µL/min
Exps. at 1.5 µL/min

Ests. at 0.8 µL/min
Ests. at 1.0 µL/min
Ests. at 1.5 µL/min

Figure 4.2. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM methyl
orange at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. n = 3 and
average ± standard deviation
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Figure 4.3. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC4 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. n = 3 and
average ± standard deviation
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Figure 4.4. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC10 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. n = 3 and
average ± standard deviation
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Figure 4.5. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC20 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4.n = 3 and
average ± standard deviation
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Figure 4.6. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC40 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. n = 3 and
average ± standard deviation
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As the molecular weight increases the deviation increases. One of the reasons for the deviation could be
fluid loss. For instance, collections of methyl orange conducted at 5.0 µL/min using 4% dextran-70 as
perfusion fluid yielded fluid losses of +8% (control), -1%, -11%, and -28% for zero (control or one probe),
one, two, and three probes connected in series respectively, see Table 4.1. This means that the
backpressure increases as the number of probes in series increases. More fluid was loss for the four probes
(-28%) in series compared to one probe (+8%), two (-1%) and three probes (-11%).
Table 4.1. Fluid losses of 100 µM methyl orange after the addition of microdialysis probes in series.
Number of probes added in series
0*
1
2
3

Fluid loss (%)
+8.40*
-1.30
-11.40
-28.40

*Control
The product kA (Figure 4.1) was determined for one probe and multiplied by the number of
microdialysis probes (n) connected in series used for the experimental data. It was assumed that the
system, in terms of hydraulic pressure, did not change from having one probe to two, three, and four probes
in series. In other words, the product kA was the same for each system or probes connected in series (kA1
= kA2 = kA3 = kA4). The product kA1 was the slope of the curve that was determined using one probe or
control. After looking at the data and the system more closely a different approach to estimate the relative
recoveries was used. The product kA was determined for each “system” individually (one probe = kA1, two
= kA2, three = kA3, and four probes = kA4). Which means that the product was different for each setting
used (kA1 ≠ kA2 ≠ kA3 ≠ kA4). This was done to take into account the fluid loss of each system. For example,
the product kA was determined for one probe and compared the estimated relative recovery versus the
experimental relative recovery of one probe. After connecting another microdialysis probe in series, the
product kA2 was determined for that system. This was done for up to four probes (kA4) connected in series.
Each probe or probes in series was treated as an individual system. The estimations and experiments
agreed considerably after using this approach, see Figure 4.7. It can be seen by comparing Figure 4.6 (kA1
= kA2 = kA3 = kA4) with Figure 4.7 (kA1 ≠ kA2 ≠ kA3 ≠ kA4) a significant improvement on the agreement.
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It is good to point out that for the microfluidic system (chapter 5) that was developed based on the
microdialysis probes in series approach, the kA value would be determined for the entire system not
individually as it was done with the microdialysis in series approach.
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Figure 4.7. Comparison of experimental (Exps.) and estimated (Ests.) relative recoveries of 100 µM FITC40 at different flow rates. The perfusion fluid used was 4% dextran-70 in 10 mM PBS pH 7.4. The
estimations were done using kA for each system individually (kA1 ≠ kA2 ≠ kA3 ≠ kA4). n = 3 and average ±
standard deviation
4.2.1

Methyl orange
Using the kA value found in Table 4.2, the relative recovery (RR) for methyl orange was estimated

to be 44.6%, 58.8%, and 67.0% at the 1.5, 1.0, and 0.8 µL/min flow rates, respectively, see Figure 4.2. The
estimated RR for four probes was 91% or greater for all three perfusion fluid flow rates. The lower flow
rates were estimated to achieve nearly 100% RR with four microdialysis probes in series. Compared to
our experimental data (48.9%, 61.3% and 66.7%), this estimation is within (5%) of our experimental results
indicating that the model described in Equation 1.6 could be used to estimate RR.
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Table 4.2. Measured mass transfer (kA) values of 100 µM solutions of methyl orange, FITC-4, FITC-10,
FITC-20, and FITC-40 using one CMA/20 microdialysis probe, slope of -ln(1-RR) vs. Q-1 at 0.8, 1.0, and
1.5 µL/min flow rates.
Solute used
kA (µL/min)
R2
Methyl orange
0.8869
0.9995
FITC-4
0.2884
0.9783
FITC-10
0.1822
0.9972
FITC-20
0.1257
0.9996
FITC-40
0.0483
0.9996

Using the kA value, from the table above (Table 4.2), and Equation 1.6, the number of probes
needed to reach 99% relative recovery (RR) for methyl orange was calculated using different perfusion fluid
flow rates. These values are shown in Table 4.3 and show the expected flow rate dependence with needing
only four probes at 0.8 µL/min and 8 probes at 1.5 µL/min to reach 99% relative recovery. Since lower flow
rates have greater residence times, it would be expected that fewer probes are necessary to achieve 99%
RR.
Table 4.3. Estimation of the number of probes needed (in series) to reach 99% relative recovery.
Flow rate (µL/min)
0.8
1.0
1.5
Solute used
Methyl Orange
4
5
8
FITC-4
12
15
22
Number of
FITC-10
19
24
35
probes
needed
FITC-20
27
34
51
FITC-40
70
87
131

4.2.2

FITC-4
Using the mass transport coefficient, kA, found in Table 4.2, the estimations for FITC-4 RR through

one microdialysis probe were 17.5%, 25.0%, and 30.3% at the 1.5, 1.0, and 0.8 µL/min flow rates. The
estimated RR for four probes was of 54% or greater. Compared to the experimental data (22.2%, 30.8%
and 34.1%), these estimations are in general agreement with our experimental results indicating that
Equation 1.6 can be used to estimate RR for FITC-4. For FITC-4, the number of estimated microdialysis
probes in series needed to reach 99% RR using the kA value in Table 4.2 was found to be 12 at 0.8 µL/min
and 22 at 1.5 µL/min (Table 4.3).
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4.2.3

FITC-10
The experimental data significantly deviated from the calculated relative recovery (RR) estimations for

FITC-10. Unlike methyl orange and FITC-4, the estimates of RR started significantly deviating from
experiments for 3 (49.5% vs. 35.5% at 0.8 µL/min) and 4 (59.8% vs. 39.4% at 0.8 µL/min) probes connected
in series. The reason for this deviation could be that for larger molecules fluid loss has a greater influence
on RR than for smaller molecules. In other words, the combination of outward convection combined with
diffusion toward the dialysis membrane lumen may significantly affect the recovery of larger molecular
weight solutes. The model used in Equation 1.6 assumes that fluid loss does not change with the number
of probe added in series.
4.2.4

FITC-20

For FITC-20, the estimated relative recovery deviated from experimental observations for 2 (27.0% vs.
15.9% at 0.8 µL/min), 3 (37.6% vs. 17.2% at 0.8 µL/min), and 4 (46.6% vs. 18.7% at 0.8 µL/min) probes in
series. Again, it is likely the convective force is greater than the diffusive force for collection of this larger
molecular weight solute.
4.2.5

FITC-40
As with FITC-20, the RR% estimations for FITC-40 deviated from experimental observations for 2

(11.4% vs. 6.0% at 0.8 µL/min), 3 (16.6% vs. 6.6% at 0.8 µL/min), and 4 (21.5% vs. 7.7% at 0.8 µL/min)
probes in series. The likely cause is the convection out of the dialysis probes at the higher probe numbers.
Conclusions
A model to predict the number of microdialysis probes connected in series necessary to achieve ~
99% relative recovery was developed. This model was used to estimate the number of probes connected
in series at different flow rates to achieve near equilibrium between the outer part of the microdialysis probe
membrane and the inner part. This work served as a basis for the development of a microfluidic system for
the collection of biomolecules. This is going to be cover in more detail in chapter 5. Additionally, one could
envision using this approach to get an estimate of in vivo concentrations and use it periodically within
experimental runs to verify in vivo concentrations.
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To continuously run with multiple probes will certainly reduce temporal resolution, but again it could be used
at the start and completion of an in vivo experiment to gain important information about biological
concentrations, without using the cumbersome in vivo calibration methods for microdialysis sampling
described in the literature.
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Chapter 5. Miniaturization of microdialysis probes in series method: Design,
microfabrication, and testing of microfluidic device
Introduction
After demostrating in chapter 3 that the microdialysis probes in series method improves the relative

recovery of different chemical compounds (methyl orange, FITC-4, FITC-10, FITC-20, and FITC-40), the
next step was to miniaturize the concept of extending the fluid path length into a microfluidic device. The
general idea was to make a prototype on polydimethylsiloxane (PDMS) similar in shape as a commercially
avaible microdialysis probe, see Figure 5.1. As previously stated in this dissertation there is a growing
interest in miniaturizing microdialysis sampling technique into microfluidic systems. 1, 2,

3

However, this in

most cases can be challenging. One of the main problems is the difficulty of incorparating pumping, valving,
and detection systems into microfluidic devices due to their large volume to flow rate ratio between their
components.1 Section 1.2.1.1 covered this topic in more detail. Several steps were taken to miniaturize the
microdialysis probes in series method into a microfluidic device. First, AutoCAD® computer-aided design
and drafting software was used to design the microfluidic device and the photoplot. The dimensions of the
design were chosen based on different factors: a) Cost of the photoplot (the smaller, ~10 µm, the features
the more expensive the photoplot), b) previous experience working with microchannels of similar size, c)
length of microdialysis probe membrane (4 mm), and d) basic fluid dynamic principles.

Figure 5.1. Commercially aviable CMA 20 microdialysis probe.
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The microfluidic device developed for this dissertation had the following dimensions: 1) Overall length of
44.0 mm (1.7”), 2) overall height of ~100 µm, 3) nine microchannels with different widths to reduce
backpressure, one of 40 µm (inlet), six of 50 µm (collection area), and two of 100 µm (outlet) respectively,
and 4) the length and width of the collection area were 4.4 mm and 2.0 mm. Finally, standard
microfabrication techniques were used.
Experimental section
5.2.1

Photoplot
Figure 5.2 shows a 2D drawing of the microfluidic device. A negative photoplot was ordered in-

house from the University of Arkansas High Density Electronics Center (HiDEC). According to Varteresian,
“A photoplot is nothing more than a high quality transparency, or view graph.”4 This means that some areas
of the photoplot would allow ultraviolet (UV) light to pass through it and other would not. The areas expose
or that allow UV to pass through it would be polymerized during the photolithography process. It is good to
point out that if a negative photoplot is used, a similar photoresist must be used as well.

Figure 5.2. 2D drawing of the microfluidic device. This drawing is not to scale to facilitate the visualization
of the microchannels.
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The drawing used to order the photoplot was designed for a 4” in diameter silicon wafer. Five replicas could
be made at the same time using this photoplot. After receiving the negative photoplot a SU-8 master mold
was fabricated.
5.2.2

Microfabrication of PDMS replicas
A master mold was fabricated using a similar procedure (Figure 5.3) previously used by the author

of this dissertation.5 Standard photosensitive polymers, SU-8 50 and SU-8 3050, from MicroChem Corp.,
Westborough, MA were used to make the master mold. Both SU-8 50 and SU-8 3050 were used due to
their in-house availability and the height of the channels (~100 µm). These two polymers can be used
interchangeably. The SU-8 50 was purchased from MicroChem and the SU-8 3050 was available at HiDEC.
The main difference between SU-8 50 and SU-8 3050 is the thickness that can be achieved during spin
coating. SU-8 50 thickness ranges from ~40 µm to ~120 µm, whereas SU-8 3050 thickness ranges from
~45 µm to ~102 µm according to their data sheets.6 Both photoresist resins can achieve the thickness range
chosen for this work. To accomplish the desire thickness or overall height of the microchannels the
MicroChem data sheet for SU-8 3000 permanent epoxy negative photoresist was followed. 6 A long pass
optical filter (PL-360-LP) from Omega Optical, Inc, Battleboro, VT was used to eliminate UV radiation below
350 nm as recommend by the SU-8 3000 data sheet.6 This optical filter was placed on top of the negative
photoplot during the exposure step of the master mold. It was found that when the optical filter was not
used during the master mold fabrication some SU-8 residues were observed after the development step
(under development). This was due to the incomplete photopolymerization of the SU-8 during the exposure
step. The permanent epoxy negative photoresist, SU-8, undergoes a phase change during
photopolymerization. Due to the fact that a partially polymerized SU-8 is not soluble in the MicroChem’s
SU-8 developer solvent and a non-polymerized SU-8 is can be used as an indicator of incomplete
photopolymerization. The SU-8 required more energy to complete the chemical reaction and change from
liquid to solid after photopolymerization. It is good to note that the exposure time was increased by 40% as
recommended by MicroChem data sheet for SU-8 3000.6 The latter in terms increased the amount of energy
applied to the SU-8 during photopolymerization (UV exposure). Figure 5.4 shows the SU-8 master mold
after microfabrication. The master mold was inspected under a regular light microscope for quality
purposes.
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After the inspection, PDMS replicas were made using the master mold and following the procedure shown
on Figure 5.3. To close the open channels on the replicas, PDMS lids were made using a silicon wafer.
These lids were basically flat pieces of PDMS with and without indentations, see Figure 5.5.

Figure 5.3. Standard microfabrication process used to make the PDMS replicas. 5 MicroChem’s SU-8
developer was used instead of propylene glycol.6

Glass slides were used as lids for some of the preliminary devices. The advantage of using glass slides
during microfabrication is that they reversibly stick to PDMS. Van der Waals forces at the surface of glass
and PDMS form a weak reversible bond between them. It is only necessary, in most cases, to bring both
surfaces together to achieve the reversible bond. This allowed the PDMS replicas to be tested using flow
rates of up to 5.0 µL/min without any surface modification, see Figure 5.6. The PDMS was made using the
standard Sylgard® 184 Silicone Elastomer Kit from Dow Corning Corporation, Midland, MI. The kit contains
a base and curing agent that are typically mixed to a 10:1 ratio by weight. The ratio used for all the PDMS
microchannels and lids fabricated was 10:1. The inlet and outlet of all the PDMS replicas were made using
a round punch of 0.71 mm cutting edge diameter purchased from Technical Innovations, Inc., Angleton,
TX.5 In some instances a round punch of 3.02 mm (Figure 5.7) cutting edge diameter was used.
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This was done when the inlet or outlet broke during the punching process (Figure 5.24, “C” or device on
the right side).

Figure 5.4. SU-8 master mold in a wafer transport box after microfabrication. Up to five PDMS replicas at
a time can be made using this mold.

Figure 5.5. Uncut PDMS replica and lid with indentation on silicon wafer before plasma treatment.
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Figure 5.6. Testing of an uncut PDMS replica under a light microscope using a glass slide as a lid. The
glass slide and PDMS replica were weakly bonded by Van der Waals forces.

Figure 5.7. Round punches used to make the inlet and outlet of the PDMS microfluidic devices. The
highlighted areas show their cutting edges. The round punch of 0.71 mm cutting edge diameter is shown
on a) and the punch of 3.02 mm is shown on b).

Each PDMS replica (open channels) was tested under a light microscope using a glass slide as a lid and
either 10 mM PBS pH 7.4 or HPLC water at a flow rate of 5.0 µL/min unless otherwise stated, see Figure
5.6. This was done before proceeding to bind the PES filters and PDMS/glass lids to the PDMS replicas.
Testing the PDMS replicas saved time and money and made sure that none of the microchannels within
the device were clogged.
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5.2.3

Microfabrication of microfluidic devices
To reach the final working microfluidic device, five assembly iterations were performed. Figure 5.8

shows all the assembly approaches that were used. Each of the assembly’s procedures and how they lead
to the next procedure will be addressed in detail later in this section. The membrane chemical composition,
polyethersulfone (PES), was chosen based on the CMA/20 microdialysis probes used in this dissertation
(Chapters 2 and 3) since they have a PES membrane. As proof of principle Whatman™ Puradisc PES
syringe filters of 25 mm in diameter and pore size of either 0.2 µm or 0.45 µm were used from SigmaAldrich, St. Louis, MO. The problem with using these syringe filters was that in order to retrieve the
membrane from the plastic case it has to be broken. Figure 5.9 shows the PES syringe filter before and
after retrieving the PES filter. Some of the grooves on the plastic case of the PES syringe filters were
present on the PES filter after retrieving them, see Figures 5.18 and 5.19. However, the PES filters were
very useful to test the effectiveness of the bonding method described by Aran et al. shown on Figure 5.10.7
Following this method, the PES filters (membranes) were treated for 1 min at a pressure of 600 mTorr and
100 W of power in an Automated Plasma Cleaning System (APE 110), see Figure 5.11. After both sides of
the membranes were treated, they were placed in a 5/95 (v:v) APTES:H2O solution of 3-amino
propyltriethoxysilane (APTES) at 80°C for 20 min. This solution was made using 99% (in water) v/v APTES
stock solution purchased from Sigma-Aldrich, St. Louis, MO. The PDMS replicas and their lids (Figure 5.12)
were treated in the APE 110 using the same parameters, but for a shorter period of time (20 s). It was found
that when silicon wafers were used (Figure 5.11 vs. Figure 5.12) after the plasma treatment, the PDMS
replicas and lids weakly attached to the wafers. This caused some problems, since they had to be physically
removed from the wafers leading to breakage in some instances. Regular office Scotch™ tape was used
to fix this problem. The silicon wafer was covered with the tape to prevent PDMS from binding to the wafer.
After the 20 min in the 5% (in water) v/v APTES solution the membranes were let dry and were brought
together to the PDMS replicas and lids. They were incubated for at least 24 hours having either a weight of
~6 pounds (Fisher Scientific Catalog 2008/09) on top or pressed using a c-clamp of 3” (Figure 5.13) to
ensure a stronger bond.7 When the c-clamp was used care was taken to make sure the microfluidic device
was not bent or broken (glass lid). This was accomplished by placing pieces of PDMS on both sides of the
device and a plastic lid under the device. The pressure was focused on the union area, see Figure 5.13.
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Figure 5.8. The five different assemblies (1-5) that were done before reaching to the final device (6): 1)
Glass slide was used as lid and chemically bound on top of the PDMS replica next to the PES (filter)
membrane (side by side), 2) same as 1), but PDMS was used as a lid, 3) PDMS lid was chemically bound
to the PDMS replica and the membrane, but one of the etches of the lid was physically pushed on top of
the etch of the membrane, 4) an indentation was made in the glass lid by drilling it and chemically bound
on top of the PDMS replica and membrane, 5) same as 4), but the indentation was made on PDMS during
curing, and 6) PES membrane was chemically bound the PDMS replica completely covering the replica
and a PDMS was bound on top of the membrane leaving the collection area open.
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Figure 5.9. PES syringe filter before and after retrieving the PES filter.

Figure 5.10. Aran et al. bonding method used to bind the PES filter to the PDMS prototype. 7 Reproduced
from reference 7 with Permission of The Royal Society of Chemistry (see appendices).
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Figure 5.11. Oxygen plasma instrument used to chemically modify the surface of PDMS replicas and PES
filters (left side). APE-110 - Automated Plasma Cleaning System (600 mTorr, 100 W).

Figure 5.12. Cut PDMS replica and lid without indentation before plasma treatment on a tape covered
silicon wafer.

84

The advantage of Aran et al’s method was its simplicity and strength of the bond formed between the PDMS
and the PES membrane. One of the drawbacks of this method is the 24 hours waiting time which is longer
(48 hours) when glass is used. The devices were tested using either HPLC grade water or 10 mM PBS pH
7.4 at 5.0 µL/min unless otherwise stated. To evaluate the quality of the bonding between PDMS and PES
membrane the devices were observed under a light microscope with and without a camera to see if any
leaks were present during perfusion, see Figure 5.14. Before the first assembly was made a simple PDMS
microfluidic device was fabricated to test the Aran et al’s binding method. The device consisted of one
straight channel of 100 µm in width and 100 µm in height, see Figure 5.15. The PES filter was used as a
lid and bound on top of the channel. Two pieces of PDMS were chemically bound at both ends of the
channel (inlet and outlet).
A simple pull test was conducted to evaluate the strength of the bond between the PES filter and
the PDMS channel. The simple pull test consisted of pulling off the PES filter after the 24 hours incubation,
see Figure 5.16. After successfully evaluating the binding method, the first assembly approach was made.
For the assembly approaches from 1 to 5 the PES filter was placed on the collection area, see Figure 5.17.

Figure 5.13. Setup used during the 24 or 48 hours incubation showing a microfluidic device pressed on the
union area using a c-clamp of 3”.
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Figure 5.14. Setup used to inspect the microfluidic devices after microfabrication. The left side shows the
perfusion fluid flowing in the channel having the PES membrane at the bottom. The microfluidic device
shown in this picture corresponds to the simple microfluidic device of one channel made to test Aran et al’s
method (Figure 5.15).

Figure 5.15. Microfluidic device fabricated to test Aran et al’s binding method.
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Figure 5.16. PDMS microfluidic device during simple pull test. Filter traces indicated the strength of the
bond and the resistance to been pulled.

Figure 5.17. Cut PDMS replica with open channels and filter bound on collection area.

First assembly approach glass lid side by side
The first assembly approach used was made using a glass slide as lid and a syringe PES filter. As
shown on Figure 5.8 1), the PES filter was first bound to the PDMS channels. After that the glass lid was
chemically bound to the PDMS channels. The glass lid was positioned on top of the channels so that the
edge of the lid and PES filter met. This was done to have the collection area covered with the PES filter
only.
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As mentioned before, the glass, PES filter, and PDMS were chemically bound using the Aran et al’s
procedure described on section 5.2.3. The microfluidic device was tested using HPLC water at a flow rate
of 2.0 µL/min. The region between the PES filter and glass lid, “union region” (Figure 5.18 and 5.19), was
where leakage occurred. To eliminate the leakage in the union region another assembly approach was
made.
Second assembly approach PDMS lid side by side
The second assembly approach used was similar than the first approach, but PDMS was used as a lid. The
idea of using PDMS was to have a more flexible material. Glass is more rigid than PDMS and that difference
could cause microgaps, see Figure 5.20. Bhattacharya reported that when glass and PDMS are chemically
bound a higher gap between the surfaces is formed.8 On the other hand, the opposite was found when two
PDMS surfaces were bound. Based on this finding, PDMS was used as a lid for this assembly. The same
binding procedure as the first assembly (5.2.3.1) was used. After testing the device with HPLC water at 1.0
µL/min the same leakage was found as the first assembly. The device was leaking through the union area.
A third assembly approach was conducted to eliminate the leakage in the union area.

Figure 5.18. Microfluidic device during quality inspection under light microscope. This was the first
assembly used (Figure 5.8 1)) during the development of the microfluidic system.
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Figure 5.19. First assembly approach used during the development of the microfluidic device showing
the union between the PES filter and the glass lid.

Figure 5.20. Diagram showing how microgaps could be formed when PDMS and glass are bound versus
PDMS and PDMS according to Bhattacharya. Redrawn from reference 8.

Third assembly approach PDMS lid on top edge
This assembly approach consisted of the same components as second assembly (5.2.3.2), but the
PDMS lid was bound at the edge of the PES filter. The idea was to apply a high pressure to a flexible PDMS
lid positioned at the edge of the PES filter, see Figure 5.8 3), during binding incubation to increase the
contact surface between the PES filter and PDMS lid. The PDMS curing time and temperature were
reduced from 1 hr to 30 min and 75°C to 70°C respectively. These changes were made to have a more
flexible PDMS. For this approach the c-clamp setup was used, see Figure 5.13. The device was leaking
after perfusing it with HPLC water at 1.0 µL/min.
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The leakage was found in the same union area. This assembly approach led to a fourth assembly with the
same purpose of eliminating the leakage and be able to conduct collection experiments.
Fourth assembly approach glass indented
To solve the leakage problem, another assembly approach was performed. This approach
consisted of using glass as a lid having an indentation of approximately 2 mm by 2 mm and depth of 60 µm
(thickness of PES filter). The indentations were made on glass slides using a rotary diamond drill bit of
3/16”. Water was used as lubricant to minimize friction. The diamond drill bit was mounted in a benchtop
drill press. The pressure applied during drilling was controlled manually. A piece of PES filter was cut and
used to verify the depth of the indentation.
When the indentation matched the thickness of the PES filter, the indented glass lid was used for the
assembly. Figure 5.21 shows the microfluidic device before binding incubation. Two glass slides (without
indentation) were used during incubation. One under the PDMS channels and the other on the PES filter
next to the indented glass slide. This was done to ensure that the pressure was evenly applied during
binding incubation. For this assembly, the c-clamp of 3” was used as well, see Figure 5.13. The device was
leaking when it was tested after binding incubation under the same conditions as the third assembly. Since
the manual drilling process added more variations to the assembly approach, another assembly approach
was developed.

Figure 5.21. Microfluidic device made using fourth assembly before binding incubation using c-clamp.
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Fifth assembly approach PDMS indented
This new assembly approach was similar than the previous assembly (5.2.3.4), but the glass lid
was replaced for PDMS, see Figure 5.8 5). For this approach the indentation on the PDMS lids were made
by placing pieces of PES filter (larger than the collection area) on a 4” silicon wafer having cardboard taped
around it. The PES filter pieces were cut larger than the collection area to make sure that the indented
PDMS lids were wider. This was done to minimize leakage. To ensure the uniformity of the indentation, the
PES filter pieces were glued using LOCTITE® super glue (gel control) to the wafer.
A thin layer of super glue was applied on the silicon wafer. To achieve a thin layer, a drop of the super glue
was placed on the wafer and scraped using a metal blade. This ensured that a thin layer of super glue was
used. After the super glue was applied on the wafer, three PES filters of 5 mm in height and 2 mm in width
were placed on the wafer. This served as a mold for the PDMS lids with indentation. The Sylgard® 184
Silicone Elastomer Kit was used to make the PDMS lid replicas on the mold (see section 5.2.2). The mold
with PDMS was incubated in an oven at 75 C° for 1 hour. After binding incubation, the three PDMS lids with
indentation were cut, see Figures 5.22 and 23. Before binding each part (PDMS lid with indentation, PES
filter, and PDMS channels), each device was assembled to make sure they fit well, see Figure 5.24. All
three microfluidic devices (Figure 5.24) were tested using 100 µm methyl orange solution and 4% dextran70 in 10 mM PBS pH 7.4 or HPLC water as perfusion fluid. The inlet of one of the devices (Figure 5.25 “C”)
was expanded using a punch of 3.02 mm cutting edge diameter. This was done to eliminate the leakage
present in the inlet during perfusion. A plastic fitting was glued to the inlet using LOCTITE® super glue. To
seal the other side of the inlet, a piece of PDMS was glued at the bottom of the plastic fitting, see Figure
5.25. The microfluidic device was leaking from the collection area (Figure 5.26) and was fixed with super
glue. After fixing the leakage using super glue flow rate verification was conducted. The flow rate was
verified using methyl orange and 4% dextran as perfusion fluid. This verification was done by collecting
three samples from the outlet every 2 min at 2.0 µL/min and measuring their weight. A regular BASi syringe
pump system (West Lafayette, IN) was used to push the perfusion fluid at 2.0 µL/min.
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Figure 5.22. Indented PDMS lids inside the mold before been cut.

Figure 5.23. PDMS lid with indentation before (uncut) and after cutting.
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Figure 5.24. Uncut and unbound microfluidic devices for fifth assembly approach.

Figure 5.25. Microfluidic device made using fifth assembly having a plastic fitting in the inlet.

Figure 5.26. PDMS microfluidic device made using fifth assembly during leakage testing using 100 µM
methyl orange solution. The red arrows indicate the leakage area where super glue was applied before
testing.
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For the gravimetric calculations, it was assumed that the density of the dialysate was 1.0 g/mL (the density
of 100 µM in HPLC was previously determined, Chapter 3, to be 0.998 g/mL ± 0.004 g/mL). The calculated
volume was 4.0 µL (collection time multiplied by flow rate). After collections, the measured flow rate or
volume delivered overtime was 4.14 µL ± 0.19 µL. This result indicates a fluid gain of 3.5%. Since a larger
fitting (Figure 5.25) was glued to the inlet, an in-house made tubing connection was used, see Figure 5.26
and 5.27. Two types of experiments were performed. The first experiment was performed by placing 7 mL
of the methyl orange solution in a 20 mL beaker, a recovery experiment (Figure 5.27), and using 4% dextran
as perfusion fluid pumped at a 2.0 µL/min rate. The second experiment was a delivery experiment in which
the methyl orange solution was placed in the syringe of the BASi syringe pump system. The latter
experimental setup can be seen on Figure 5.28. The flow rates used was this experiment 1.0 µL/min. No
recovery or delivery was observed during these experiments. This was determined by measuring the
absorbance of the dialysate using the NanoDrop 2000 UV-Vis spectrophotometer from Thermo Scientific
(Wilmington, DE), data not shown here. Since super glue was used to fix the leakage from the membrane
(Figure 5.26), this could have clogged the pores of the membrane. The super glue could have diffused into
the pores clogging them. A microgap was found in the microfluidic devices explaining why the devices were
leaking from the union area close to the membrane and collection area, see Figure 5.29.

Figure 5.27. Collection of methyl orange experiment using microfluidic device made with fifth assembly
approach.
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Figure 5.28. Setup used to test the microfluidic device made with the fifth assembly approach. Delivery
experiments.

The other two devices (Figure 5.24 “A” and “B”) were leaking as well after testing with HPLC water at 0.5
µL/min and 1.0 µL/min respectively. Figure 5.30 shows microfluidic device “B” during leakage testing. Unlike
microfluidic device “C”, the other two devices’ inlet and outlet were made using a 0.71 mm round punch.
This facilitated the tubing connections. The next logical step would have been to conduct this assembly
approach under a microscope to make sure that microgaps were not present. However, one last assembly
approach was developed to eliminate all the problems with the leakage. Before conducting this last
assembly approach, the PES filter was tested to make sure that transport was occurring across the filter.

Figure 5.29. Microgap formed after assembly approach number 5 was used. This microgap was located at
the union region between the PES filter and the PDMS lid.
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Figure 5.30. Microfluidic device made using assembly number 5 been tested using HLPC water under a
light microscope.

5.2.3.5.1

Equilibrium dialysis

To evaluate whether or not analyte transport was occurring across the PES filter an equilibrium
dialysis experiment was conducted. A micro-equilibrium dialyzer of 25 µL from Harvard Apparatus
(Holliston, MA) was used, see Figure 5.31. In one chamber 25 µL of 10 mM PBS pH 7.4 were pipetted and
in the other chamber the same volume of 100 µM methyl orange (diluted in the same buffer) was placed.
The total volume used was 50 µL. A Whatman™ Puradisc PES syringe filter of 25 mm in diameter and pore
size of 0.2 µm purchased from Sigma-Aldrich, St. Louis, MO was used. As previously mentioned the syringe
filter was broken to retrieve the filter. After retrieving the filter, it was cut using a regular office scissors to
the size of the chamber. The micro-equilibrium dialyzer was placed horizontally (as shown on Figure 5.31)
on a bench for 1 hour and 22 minutes at room temperature. The concentration of methyl orange in each
chamber was measured using an UV-Vis spectrophotometer (NanoDrop) after incubation. The results were
reported as percent recovery. The measured concentrations of methyl orange were related to the initial
concentration of methyl orange used (100 µM). It was found that a 49.7% of methyl orange was present in
chamber 2 and a 41.4% in chamber 1. These results showed that transport across the PES filter occurred
indicating that the PES filter was not the source of the problem with the microfluidic device.
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Figure 5.31. Schematic representation of the micro-equilibrium dialyzer used for the equilibrium dialysis
experiment performed to test the PES filter transport.

Sixth assembly approach using UE50 membrane
The last assembly approach used to solve the leakage problem with the microfluidic system was
conducted, see Figure 5.8 6). This assembly approach consisted of covering the PDMS replica with open
channels using a PES membrane and used a flat PDMS as a lid. The collection area was only covered with
the PES membrane to allow the transport of molecules across it. The idea was to eliminate the need for
indentations or precision alignments during assembly. The sixth approach significantly simplified the
microfabrication of the microfluidic device. To test this approach, TriSep UE50 flat-sheet polyethersulfone
(PES) ultrafiltration membrane of 100 kDa (MWCO) from Sterlitech Corporation, Kent, WA was used. This
flat-sheet membrane had two distinct roughness in each side. One side was called “shiny” and the other
side “dull”. The latter had a hair-like roughness, see Figure 5.32. According to Sterlitech, this difference is
caused by their manufacturing process. They stated that the “shiny” side indicates tighter pores. This
difference caused a problem during the microfluidic device assembly and will be addressed later in this
section. The PDMS channels, PDMS lids, and PES membranes were attached chemically using the Aran
et al’s binding method (Figure 5.10 and 5.11). After the plasma and APTES treatments the “dull” side (Figure
5.32) of the PES membrane did not bind to the PDMS lid as the “shiny” side of the membrane. As soon as
the “shiny” side of the membrane and PDMS channels were brought into contact a bond was formed. The
same observation was reported by Aran et al (7). As previously mentioned, the “dull” side of the membrane
caused a problem during the assembly process.
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Figure 5.32. PDMS microfluidic device made using TriSep UE50 flat-sheet PES membrane. The roughness
of the “dull” side can be seen in this picture. A glass slide was used to carry the device.
When the “dull” side and PDMS lid were brought into contact, they did not form a bond. This was visually
observed as both parts did not attach or fell apart. To fix this problem, the surface of the “dull” side of the
membrane and PDMS lid were treated using the APE 110 oxygen plasma at 600 mTorr and 100 W for 20
seconds. To increase the oxygen exposure to the surface and activate the surface. After one trial, the
membrane and PDMS lid formed a bond and were incubated accordingly to ensure that a stronger bond
was achieved. Figure 5.33 shows one of the four PDMS microfluidic devices made using the new
membrane during leakage inspection. The microfluidic devices were inspected for leakage under a light
microscope by pumping a solution of 10 mM PBS pH 7.4 at a 1.0 µL/min rate, see Figure 5.33. During this
test the flow rate from the outlet of one of the microfluidic devices was measured gravimetrically. Two
samples were collected every 5 minutes at the same pumping rate (1.0. µL/min).
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It was assumed that the PBS density was 1.0 g/mL. Based on this assumption, the average (n = 2) amount
of PBS delivered from the microfluidic device was 4.7 µL.

Figure 5.33. PDMS microfluidic device (UE50) during leakage inspection under a light microscope.
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Compared to the delivered theoretical volume of 5.0 µL, calculated using the collection time and pumping
rate, the delivered measured volume (4.7 µL) was only 0.3 µL off. This indicated that only a small amount
of fluid was loss across the membrane. After inspection, the devices were tested using 0.9 mM methyl
orange in HPLC water as the analyte and PBS as perfusion fluid. Recovery and delivery experiments were
performed on the devices. For the recovery experiments, the methyl orange was placed in either a 20 mL
glass beaker (Figure 5.34) or a plastic petri dish (Figure 5.35). The methyl orange solution was placed in
the syringe during the delivery experiments, see Figure 5.36. Of the four devices, two devices broke apart
(Figure 5.37). After the 24 hours binding incubation, the PDMS lids came off. This indicated that a very
weak bond was formed between the PES UE50 membranes (“dull” side) and PDMS lids. However, the
other two microfluidic devices were successfully tested and not leakage were found.

Figure 5.34. Experimental beaker set up used for recovery experiments performed on the PDMS
microfluidic devices having UE50 PES membranes.
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Figure 5.35. Recovery experiments performed using a plastic petri dish on the PDMS microfluidic devices
(UE50 PES membranes).

Figure 5.36. PDMS microfluidic device (UE50 PES membranes) during methyl orange delivery experiment.
The orange marks indicated the methyl orange flow path inside the device.
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Figure 5.37. PMDS microfluidic devices after binding incubation using UE50 PES membranes. The PDMS
lids detached from the PES membranes.

These microfluidic devices were further tested as previously mentioned by either recovering methyl orange
or delivering it in the device (Figures 5.34, 5.35, and 5.36). The recovery experiment conducted at 1.0
µL/min for 7 hours and 31 minutes, yielded dialysates not detectable by the NanoDrop 2000 UV-Vis
spectrophotometer. Figure 5.38 shows physical appearance of the UE50 PES membrane after the recovery
experiment was conducted. The fact that a lack of orange color was observed (see Figure 5.36 for color
reference), could indicate that transport across the membrane was very poor or at an undetectable level
(absorbance ≤ blank = PBS). After this result, the delivery experiment was conducted. The microfluidic
device was placed in a beaker containing PBS and a methyl orange solution of 0.9 mM was delivered at a
pumping rate of 5.0 µL/min into the device. A higher flow rate (1.0 µL/min vs. 5.0 µL/min) was chosen for
the delivery experiment (Figure 5.36) to increase the amount of methyl orange delivery across the
membrane. The same result as the recovery experiment was found. The dialysates measured
spectrophotometrically were below the limit of detection. The orange marks shown on Figure 5.36 indicates
that the methyl orange was flowing in the microfluidic channels and not leakage was present. One of the
reasons why methyl orange was not detected during the delivery experiments, could be dilution. The
amount of methyl orange delivered into the beaker could be negligible compared to the PBS in the beaker.
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Figure 5.38. PDMS microfluidic device showing the wettability of the UE50 PES membrane during recovery
experiments. This was one of the indications of poor transport across the membrane.

To elucidate whether the problem was the transport across the membrane or not, the UE50 PES membrane
was tested using the equilibrium dialysis technique (see section 5.2.3.5.1 for details). This experiment was
conducted by Dr. Sarah Phillips. According to Phillips, the equilibrium dialysis experiment was conducted
using a solution of 200 µM FITC-10 diluted in ringer. She found that the recovery of FITC-10 after 13 hours
and 30 minutes was ~6%. The equilibrium dialysis experiment of FITC-10 led to a new and final PES
membrane. The sixth and final assembly approach was chosen as the more effective to make the
microfluidic device, since not leakage was observed during testing or experiments. Nevertheless, the
microfluidic devices made with the UE50 membranes did not work on either recovery or delivery mode. To
solve both the membrane transport and membrane-PDMS binding problems, a new PES membrane was
selected. The experiments conducted in the section were instrumental for the development of the
microfluidic device. One important finding was how the roughness of the PES membrane surface affected
the strength of the chemical bond formed between the membrane and PDMS. The next section will cover
the results of changing the UE50 PES membrane.
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5.2.3.6.1

Sixth assembly approach using PES019025 membrane

After six assembly iterations, the problem with the leakage found in the microfluidic devices was
solved. The problem was solved by having a PES membrane covering the microfluidic channels of the
device. This approach was simple and significantly reduced the need to have a precise assembly when
only the collection area was covered in previous assemblies. However, for future further developments of
the microdialysis-based microfluidic device engineered during this dissertation, the amount of PES
membrane should be used reduce to minimize cost. Chapter 6 will cover the latter in more details.
Materials and methods
Flat polyethersulfone (PES) membrane filters of 90 mm in diameter and pore size of 0.1 µm were
purchased from Sterlitech Corporation, Kent, WA. The thickness of the membrane was ~150 µm. This was
determined using an in-house micrometer. This was within the Sterlitech thickness range for this type of
membrane (110-150 µm) found on their website.9 A solution of 5% (in water) v/v of 3-amino
propyltriethoxysilane (APTES) was made using 99% v/v APTES stock solution purchased from SigmaAldrich, St. Louis, MO. The 5% v/v APTES solution was used to chemically modified the surface of the PES
membrane during the Aran et al’ binding method (Figure 5.10). This method was previously described in
detail on section 5.2.3. The transport of 100 µM methyl in 10 mM PBS pH 7.4 solution across of the PES
membrane was determined using equilibrium dialysis (see section 5.2.3.5.1) after plasma and APTES
treatments. The solution of methyl orange was placed in one chamber (25 µL) and the PBS was placed (25
µL) in the other chamber. The micro-equilibrium dialyzer (Figure 5.31) with the solutions was incubated at
room temperature for 2 hours.
The microchannels and lids were made using the standard Sylgard® 184 Silicone Elastomer Kit
from Dow Corning Corporation, Midland, MI. The kit contains a base and curing agent that are typically
mixed to a 10:1 ratio by weight. This kit was used to make the PDMS and the curing time and temperate
used were 1 hr and 75 °C. The master mold was made using SU-8 3050 from MicroChem Corp.,
Westborough, MA. The same procured as described on section 5.2.2 was used. The PDMS microfluidic
device was tested using a BASi syringe pump system (West Lafayette, IN) at pumping rates of 1.0, 2.0,
and 5.0 µL/min.
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The perfusion fluids used were 10 mM PBS pH 7.4 and 4% dextran-500 in 10 mM PBS pH 7.4. The amount
of dialysate exiting the outlet of the microfluidic device over time was determined gravimetrically. This was
performed to determine the fluid loss across the membrane. Push-pull experiments were conducted on the
microfluidic device using a MAB-20 microdialysis pump from Microbiotech, Stockholm, Sweden. The
following sequence was used for the push-pull experiments to find the optimal setting: a) 1.0-4.0 µL/min, b)
0.5-4.0 µL/min, c) 0.5-5.0 µL/min, d) 0.2-5.0 µL/min, e) 0.2-3.0 µL/min, f) 0.2-2.0 µL/min, and g) 0.2-1.0
µL/min. The last setting (0.2-1.0 µL/min) was performed on microdialysis probes having PES membranes
of 100 kDa MWCO and length 10 mm (CMA/20) and 4 mm (CMA/12) respectively. These microdialysis
probes were purchased from Harvard Apparatus, Holliston, MA. The analyte used was methyl orange. A
solution of 0.9 mM methyl orange in HPLC water was used for the experiments. Push or regular
microdialysis experiments were performed at 0.2 µL/min and 1.0 µL/min on the device. The latter flow rate
was used for relative recovery experiments performed on a CMA/12 microdialysis probe. The perfusion
fluid used for push and push-pull experiments was 4% dextran-500 in 10 mM PBS pH 7.4.
Theoretical estimations were made to evaluate the difference in fluid transport properties between
the three systems (microfluidic device, CMA/12, CMA/20). The surface area of the membrane, linear
velocity, pressure drop, and the resistance to flow were estimated for each system. The log mean surface
area (𝒮𝓂 ) was used to estimate the surface of the microdialysis probes. 10 For the microfluidic device, the
pressure drop was estimated using an aspect ratio (a) of 0.5. Phosphate buffer saline was assumed to be
the perfusion fluid. A pumping rate of 1.0 µL/min and temperature of 25 °C were also used for the
estimations. These calculations were performed to further improve the performance of the microfluidic
device in the future. Table 5.1 shows the equations used for the estimations. It was assumed, for the
estimations, that the collection area of the device was a straight channel, see Figure 5.39. This was done
to simplify the calculations.
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Table 5.1. List of equations used to estimate the fluid transport properties of the three systems.
Microdialysis probes
Microfluidic device
(𝑟𝑜 − 𝑟𝑖 )
𝒮𝓂 = 2𝜋𝐿𝑚 ∙
Surface area10
Surface area = width * length
𝑟
ln [ 𝑜 ]
𝑟𝑖
𝑄
𝑄
𝑣=
𝑣=
Linear Velocity5
𝐴(𝑎𝑟𝑒𝑎)
𝐴(𝑎𝑟𝑒𝑎)
2
𝐿 𝜌𝑉𝑎𝑣𝑔
*Pressure drop10,11
Δ𝑝𝑎 = ℜ𝑎 ∙ 𝑄
ΔP = 𝑓
𝐷 2
8𝜂 ∙ 𝐿𝑚
12𝜂𝐿
1
ℜ𝑎 =
𝑅ℎ =
5,10
4
2
2
3
**Resistance to flow rate
ℎ
1 − 𝜍 + [1 − 𝜍 ]
1 − 0.63 ( ) ℎ 𝑤
𝜋𝑟𝑖 4 ∙ (
)
𝑤
ln[𝜍]
*𝑓 =

24
𝑅𝑒

(1 − 1.3553𝑎 + 1.9464𝑎2 − 1.7012𝑎3 + 0.9564𝑎4 − 0.2357𝑎5 ) from reference 11.

** ℎ = height and 𝑤 = width from reference 5.

Figure 5.39. Schematic representation of microfluidic device collection area. For the estimations this area
was assumed to be a straight channel to simplify the estimations.

Results and discussion
Analyte transport across the PES membrane was similar as the PES filters (section 5.2.3) first used
to make the microfluidic devices. After the two hours incubation, the relative recovery was 44.74% ± 0.64%
(n =3) from the chamber with methyl orange and 43.26% ± 2.22% (n = 3) from the chamber with PBS. The
equilibrium dialysis results indicated that transport across the PES membrane was not an issue.
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The fluid loss across the membrane of the PDMS microfluidic device was 36.10% ± 2.25% (n = 3) when a
solution of 4% dextran-500 in 10 mM PBS pH 7.4 was pumped into the device at a rate of 5.0 µL/min for 2
min. On the other hand, a fluid gain of 4.10% ± 0.98% (n = 3) was observed when 10 mM PBS pH 7.4 was
used. These results indicated that an increment in the internal pressure of the microfluidic device when 4%
dextran-500 was used. This is due to the viscosity differences between the 4% dextran-500 solution (~1.18
mPa.s) and PBS (~0.89 mPa.s). A fluid gain is typically observed during regular microdialysis sampling
experiments. The fluid gain for the CMA/12 microdialysis probe at 1.0 µL/min using 4% dextran-500 in PBS
as perfusion fluid was 3.37% ± 0.06% (n = 3). The fluid loss across the membrane of the device increased
with the pumping rate. The fluid loss across the membrane was measured at pumping rates of 2.0 µL/min
and 1.0 µL/min using 4% dextran-500 as perfusion fluid. It was found that the fluid loss at 2.0 µL/min was
26.40% ± 3.80% (n = 3) and at 1.0 µL/min was 22.30% ± 2.40% (n = 3). At lower pumping rates the fluid
loss across the membrane is reduced. This means that the hydraulic pressure generated by the syringe
pump is smaller. When 4% dextran-500 was pumped at 5.0 µL/min into the device a bubble was observed
at the collection area, see Figure 5.40. The bubble indicated that a higher internal pressure was generated
at the pumping rate. The bubble was smaller when slower pumping rates were used (Figure 5.41) and no
bubble was observed when PBS alone was used. The relative recovery of methyl orange at 0.2 µL/min was
8.41% ± 0.31% (n = 2) and at 1.0 µL/min was 1.64% ± 0.22% (n = 3). These results showed that the
microfluidic device was able to collect methyl orange, but that the device needs to be optimized.
As a comparison, the relative recovery of methyl orange was determined using a CMA/12
microdialysis probe at a pumping rate of 1.0 µL/min. CMA/12 microdialysis probes have PES membranes
of 4 mm length and the device has a collection area length of ~4.4 mm. The relative recovery was 30.60%
± 1.35% (n = 3). One of the reason why the device yielded a lower relative recovery than the microdialysis
probe could be that the microfluidic device has a thicker membrane. Microdialysis probes have a membrane
thickness of 50 µm, but that thickness includes the supporting layer. The active layer is of ~5 µm thick. In
contrast, the thickness of the microfluidic device membrane is ~150 µm. The thickness of the microfluidic
device significantly reduced the transport across the membrane. Push-pull experiments were performed to
increase the transport across the membrane based on the latter results. The optimal setting for the
microfluidic device during push-pull experiments of methyl orange was found to be 0.2 µL/min-1.0 µL/min.
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Figure 5.40. PMDS microfluidic device during flow verification testing using 4% dextran-500 in 10 mM PBS
pH 7.4 as perfusion fluid pumped at 5.0 µL/min. A bubble was formed at the collection area during testing.

Figure 5.41. Microfluidic device during fluid verification testing at 2.0 µL/min using 4% dextran-500 as
perfusion fluid. A small bubble was observed at the collection area during this experiment.
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The relative recovery of methyl orange using this setting was 78.78% ± 2.46% (n = 3). The same setting
was used on CMA/20 and CMA/12 microdialysis probes. The relative recovery of these probes was 89.38%
± 0.91% (n = 3) and 88.29 ± 2.88% (n = 3), respectively. The difference in relative recoveries of the
microfluidic probes and the microfluidic device was significantly smaller during push-pull experiments than
push experiments. Based on these results it can be stated that the thickness of the membrane is the main
source for a lower relative recovery as compared to the microdialysis probes. Figure 5.42 shows the relative
recoveries of the full sequence used for the push-pull experiments performed on the microfluidic device.
The full sequence was compared to the push-pull recoveries of the CMA/20 and CMA/12 microdialysis
probes. All the experiments were conducted on uncut microfluidic devices, see Figure 5.43. This was done
to reduce time and minimize the possibility of breaking the device. Figure 5.44 shows the microdialysis
probes in series approach before and after miniaturization into the PDMS microfluidic device.

100.0

Methyl Orange

90.0
80.0

RR (%)

70.0
60.0
50.0
40.0
30.0
20.0
10.0
0.0

Pumping conditions used
Device

Probe CMA 12

Probe CMA 20

Figure 5.42. Comparison of relative recovery of methyl orange performed on the microfluidic device and
microdialysis probes (CMA 20 and CMA 12) under different pumping conditions. Note that for push at 0.2
µL/min n = 2 and for the rest n = 3 and average ± standard deviation
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Figure 5.43. Cut and uncut PDMS microfluidic devices. Uncut microfluidic devices were the only one used
for testing.

Figure 5.44. Microdialysis probes in series system, left, miniaturized into a PDMS microfluidic device, right.
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The results of the estimations, performed to further elucidate the source of variation between the
relative recovery of the device and the two microdiaysis probes, are shown on Table 5.2. These estimations
indicated that the microfluidic device had a surface area three and seven times smaller than the CMA/12
and CMA/20 microdialysis probes, respectively. As previously stated, the surface area of the membrane is
directly related to the relative recovery. This means that the device could be further improved by increasing
the surface area of the membrane. The linear velocity and resistance to the flow for the microfluidic device
were higher than the microdialysis probes. Consequently, the residence time of the device was shorter than
the microdialysis probes, limiting the relative recovery of the device. Increasing the residence time of the
collection area in the device could further improve the relative recovery.

Table 5.2. Surface area, linear velocity, pressure drop, and resistance to the flow estimations for the
microfluidic device, CMA/12 and CMA/20 microdialysis probes. The results of the push-pull experiments
were added as reference.
Membrane
Surface area
𝒗
𝕽𝒂 or 𝑹𝒉
Δ𝒑𝒂 or 𝚫𝐏
Push-pull
Type of system
length (mm)
(mm2)
RR (%)
(m/s)
(Pa.s/m3)
(Pa)
-3
12
Microfluidic device
4.4
~2
5 x 10
3 x 10
56
78.78 ± 2.46
CMA/12 probe
4.0
~6
8 x 10-4
8 x 1010
8 x 1010
88.29 ± 2.88
CMA/20 probe
10.0
~14
9 x 10-4
2 x 1011
2 x 1011
89.38 ± 0.91

Conclusions
After multiple iterations (7), a PMDS microfluidic device able to mimic current microdialysis sample
probes was developed. The microfluidic device was able to collect 8.41% ± 0.31% (n = 2) and 1.64% ±
0.22% (n = 3) of methyl orange when push experiments were performed at 0.2 µL/min and 1.0 µL/min
respectively. Compared to the relative recovery (30.60% ± 1.35% (n = 3)) of methyl orange collected using
a CMA/12 microdialysis probe at 1.0 µL/min and under the same conditions, the relative recovery of methyl
orange from the device was very low. This indicates that the microfluidic device is collecting molecules, but
still needs to be optimized. One of the sources of the devices poor performance could be the thickness of
the PES membrane used. The thickness of the hollow fiber membrane used with commercial microdialysis
probes are 50 µm (including support layer, ~45 µm) and the thickness of the flat PES membrane used for
the device was ~150 µm. This difference in thickness could increase the resistance of the membrane during
the experiments reducing the performance of the device. The influence of thickness on the performance of
the microfluidic device was elucidated when push-pull experiments were conducted.
111

The optimal setting for the push-pull experiments was found to be push at 0.2 µL/min and pull at 1.0 µL/min.
The push-pull results showed that the microfluidic device was able to perform at the same level than
microdialysis probes without any optimization.
The relative recovery of methyl orange collected using the microfluidic device was 78.78% ± 2.46%
(n = 3) and for the microdialysis probes was 89.38% ± 0.91% (n = 3) and 88.29 ± 2.88% (n = 3) for CMA/20
and CMA/12 respectively. The work shown on this chapter could be the first step into minimizing the need
for microdialysis calibration methods. The microfluidic device developed for this dissertation could be further
optimized to achieve the same or better performance as the microdialysis probes in series method. This
could be done by using a thinner (4 µm) PES membrane for the microfluidic device and increasing the
surface area of the membrane.
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Chapter 6. Conclusions and Future Work

Conclusions
The growing interest in developing microdialysis-based microfluidic devices, increasing the
efficiency (relative recovery) of microdialysis sampling method, and eliminating the microdialysis sampling
cumbersome and time-consuming calibration methods, were the main factors for the research work
presented in this dissertation. A new sampling method coined “microdialysis probes in series” was
developed using microdialysis sampling probes connected in series. The microdialysis probes in series
method was devised after working with the recycling flow method previously used by several researchers. 13

The recycling flow method was described in detail in Chapter 2. The new method improved the efficiency

of microdialysis sampling by 33% for methyl orange and 2% for FITC-40 when experiments were conducted
at a pumping rate of 0.8 µL/min. The method was more effective for small molecules such as methyl orange
(MW = 330 Da), FITC-4 (MW = 4,000 Da), and FITC-10 (MW = 10,000 Da). On the other hand, when larger
molecules were collected using this method the efficiency was lower. For example, the efficiencies of FITC20 (MW = 20,000 Da) and FITC-40 (MW = 40,000 Da) were 4% and 2% respectively when collected at 0.8
µL/min. The microdialysis sampling probes used for this work had a concentric semi-permeable
polyethersulfone membrane of 10 mm in length and molecular weight cutoff of 100,000 Da. One of the
reasons for the lower efficiencies could be that the molecular weight cutoff of the microdialysis probes used
were either closer or over the recommend values. The Harvard Apparatus Company that makes the
microdialysis probes used for this work recommend choosing the molecular weight cutoff based on the
molecular weight of the target analyte. They suggest to use microdialysis probes having membranes with
molecular weight cutoff of four times the molecular weight of the target analyte. 4 This means in order to
efficiently collect a molecule of 40 kDa, a microdialysis sampling probe having a MWCO of 120 kDa should
be chosen. However, the FITC-20 or 20 kDa molecule still within the MWCO of the microdialysis sampling
probe used for this work (100 kDa). Molecular weight cut off alone cannot explain the poor efficiency of the
microdialysis probes.
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A mathematical model based on Bungay’s and Jacobson’s methods was used to estimate how
many probes in series were necessary to reach equilibrium between the inner and outer concentrations of
analyte in the microdialysis probes. For small molecules like methyl orange and FITC-4 the model was in
close agreement with experiments (section 4.2), but for larger molecules like FITC-10, FITC-20, and FITC40 the model started deviating from experiments. For instance, the model predicted a relative recovery of
methyl orange collected using four probes in series at a flow rate of 0.8 µL/min to be 98.8% compared to
99.7% ± 0.9% obtained experimentally. On the other hand, for the same conditions the relative recovery of
FITC-40 was predicted to be 21.4% compared to 7.7% ± 0.1% obtained experimentally. However, after
taking into account the fluid loss the model predictions were in agreement with experiments (Figure 4.7). A
better understanding of how osmotic, transmembrane, and hydraulic pressures influence the efficiency
(RR) of the microdialysis probes in series method during collection of molecules, could be valuable to
develop a microdialysis-based microfluidic device. If the balance of those forces is understood for the
microdialysis probes in series method, a microfluidic device could be engineering taking advantage of them.
The microdialysis probes in series method was miniaturized into a PDMS microfluidic device. This
microdialysis-based microfluidic system was able to mimic a regular microdialysis probes efficiency under
certain conditions (e.g., push-pull). For example, the collections conducted at a pushing rate of 0.2 µL/min
and pulling rate of 1.0 µL/min using methyl orange as analyte were 78.8% ± 2.5%, 88.3% ± 2.9%, and
89.4% ± 0.9% using the microdialysis-based microfluidic system, CMA/12, and CMA/20 microdialysis
probes respectively. These results indicated that the microdialysis-based microfluidic device needs further
optimization.
Future Work
One of the future work that could be done to elucidate the poor efficiency of the microdialysis
sampling probes in series for large molecules is to study different compounds with uniform radius of gyration
and different molecule weights. This would minimize the influence of the molecular conformation during the
experiments. More experiments should to be done using the microdialysis probes in series method. One of
the experiments that should be done is an experiment placing each microdialysis sampling probe in series
(4) in separate vials.
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This experiment would show the contribution of each connection to fluid loss or how much pressure is
generated at each point. As mentioned before in Chapter 1 section 1.5.2.2, several researcher have devised
methods to systematically regulate the pressure inside and outside of a microdialysis sampling probe to
find optimal conditions, see Figure 1.15.5 However, as far as this author knows, the same type of
experiments have not be done using microdialysis probes in series. A similar experiment like Chu et al.
could be performed using their chamber, but connecting four microdialysis probes in series. For their work,
they did not connect each probe in series. Using a chamber like the one show on Figure 1.15 would simplify
the study of how the osmotic, transmembrane, and hydraulic pressures influence the relative recovery of
molecules. This would lead to the optimal conditions of the microdialysis probes in series for different
molecules. The work done by Chu et al. showed how those forces influenced the relative recovery of one
microdialysis probes. The information obtained about those forces during microdialysis probes in series,
would lead to the design of a more efficient microdialysis-based microfluidic system.
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